0001 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION 2 3 4 5 6 SEC ADVISORY COMMITTEE ON SMALL AND EMERGING COMPANIES 7 OPEN MEETING 8 9 10 11 Tuesday, September 17, 2013 12 9:30 a.m. 13 14 15 16 17 U.S. Securities and Exchange Commission 18 100 F Street, N.E., Washington, D.C. 19 Station Place 1 Multipurpose Room 20 21 22 23 24 Diversified Reporting Services, Inc. 25 (202) 467-9200 0002 1 3 4 ADVISORY COMMITTEE MEMBERS PRESENT: 5 Stephen M. Graham, Co-Chair 6 M. Christine Jacobs, Co-Chair 7 A. Heath Abshure 8 John J. Borer III 9 Dan Chace 10 Milton Chang 11 Leroy Dennis 12 Shannon L. Greene 13 Richard L. Leza 14 Kathleen A. McGowan 15 Catherine V. Mott 16 Pravina Raghavan 17 Tim Walsh 18 Gregory Yadley 19 PANELISTS: 20 Alex F. Cohen 21 Marianne Hudson 22 Jeffrey M. Solomon 23 Joel H. Trotter 24 David Verrill 25 0003 SEC Staff: 1 Mary Jo White, SEC Chair 2 Luis Aguilar, SEC Commissioner 3 Keith Higgins, Director of the SEC Division of Corporation Finance 4 Jonathan A. Ingram, Acting Chief Counsel, SEC Division of Corporation Finance 5 Johanna V. Losert, Special Counsel, SEC Office of Small Business Policy 6 Mauri Osheroff, Associate Director, SEC Division of Corporation Finance 7 Karen Wiedemann, Attorney Fellow, SEC Office of Small Business Policy 8 Ted Yu, Senior Counsel to the SEC Director of the Division of Corporation Finance 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 0004 1 C O N T E N T S 2 PAGE 3 Call to Order and Opening Remarks 4 4 General Solicitation 23 5 Bad Actor Disqualification 27 6 Regulation D and Form D Proposals 34 7 Presentation by Angel Capital Association 53 8 Discussion of Amendments to Regulation D 76 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 0005 1 P R O C E E D I N G S 2 OPENING REMARKS 3 MR. GRAHAM: Okay. Let's get started. Ted, do 4 we have a quorum? 5 MR. YU: Yes, we do. 6 MR. GRAHAM: Okay. One administrative note. 7 Could you make sure that you keep your cellphones away 8 from the mic because it does cause feedback. Well, 9 welcome to all the committee members. It's good to see 10 you again. Once again, thank you for your time and 11 effort. Thank you for your time and effort over the past 12 two years. It's been time I think well spent and time 13 that has gone by quickly. We also want to thank the SEC 14 staff for all of their help. 15 Before we get started, I'd like to introduce 16 our newest committee member Pravina Raghavan. Is Pravina 17 here? Were you just waiting to be called? 18 CHAIR WHITE: It's called responding to a cue, 19 right? 20 MR. GRAHAM: Yes. 21 CHAIR WHITE: Welcome also. 22 MR. GRAHAM: Yes. Pravina has been appointed 23 by Chair White to serve as the committee's SBA observer. 24 And she is the Acting Associate Administrator in the 25 SBA, with over 15 years of experience in providing 0006 1 advisory services to businesses in all phases of their 2 growth. And before joining the SBA, Pravina was a vice 3 president with MTV and BET networks and was a small 4 business owner of a strategic advisory firm that assisted 5 companies with their growth plans. Pravina, we're very 6 happy to have you with us. Thank you. 7 As you know, this committee was created by the 8 SEC in 2011 for a two-year term which expires October 9 4. October 4 is just around the corner, and we understand 10 that the Commission is considering the possibility of 11 renewing the committee for another term. But in this 12 connection Chris and I took the opportunity to speak 13 individually to nearly all of you to talk about the past 14 and the future. And we'd like to share two comments and 15 observations that resulted from this conversation. So at 16 this time I'd like to turn it over to Chris. 17 MS. JACOBS: Thank you. The purpose of these 18 one-on-one calls was an end-of-term sort of report card, 19 and to provide Stephen and I feedback about the process, 20 about what we accomplished over the two years and to hear 21 your thoughts and your experiences. Our calls each 22 lasted less than 15 minutes unless members needed more 23 time. Two members did, Catherine Mott and John Borer. 24 We granted them the extra time. They brought issues 25 before the Committee, which we are going to hear about 0007 1 today. 2 The comments that we heard from these calls 3 with committee members fell into sort of four buckets of 4 comments. The first bucket was sort of a self-report 5 card, more reflective comments, maybe personal comments 6 about the experience of being on the committee. You felt 7 it was a privilege to serve, felt it was a great 8 experience, learned a lot. A couple of quotes, "We did 9 things and we did a good job.” “We did a lot with our 10 seven recommendations that we put in over the two years." 11 And lastly, that it was an honor to be asked to help. 12 The second bucket was agency or SEC specific 13 comments. One member in particular found the agency to 14 be sincere and had an admiration for their current 15 challenges. Others felt that it was good to see that the 16 SEC was genuinely interested in our issues. There had 17 been sort of an unfortunate turnover of talent top down, 18 and there was worry that perhaps we would have lost 19 momentum along the way. Some of you were a tad skeptical 20 about the overall commitment to change and to address 21 some of our issues. 22 But generally, except for one of our members 23 who said we should go slower and be more thoughtful, 100 24 percent of the balance of our committee overall felt some 25 frustration at seeing movement on our recommendations, 0008 1 saying things like, "We wish that the SEC could do 2 something with our suggestions.” “We sure hope the SEC 3 moves on our issues, and this is all taking too long." 4 The third bucket was about Stephen's and my co- 5 chair responsibilities. It was noted that there was no 6 idle chatter, productive, that we kept the meetings going 7 and that we invited disparate views. The last bucket of 8 comments from you at the committee was about the SEC 9 staff that we deal with day in and day out. To a member, 10 you said, "Thank you to the SEC staff for a job well 11 done. Felt that you all had done a great job on 12 speakers." One hundred percent of the committee was 13 supportive of the staff that we have encountered over the 14 past two years. And lastly the quote that we like the 15 most was that “the staff had been impressive and 16 dedicated.” And with that I will end the comments from 17 the one-on-one meetings. 18 MR. GRAHAM: Thank you, Chris. Well, we 19 certainly hope that the committee's term will be renewed, 20 as we believe that it's important to have a meaningful 21 way through which the needs of the smaller public 22 companies and emerging private companies can be discussed 23 and presented to the SEC for its consideration. We have 24 managed to accomplish a great deal over the past two years in 25 terms of making recommendations and raising awareness. 0009 1 Seven of those recommendations -- we did make 2 seven recommendations. And among them, of course, the 3 recommendation dealing with general solicitation, the 4 recommendation dealing with raising the Reg A+ limits and 5 also the recommendation dealing with raising the 6 thresholds that would trigger public reporting on the 7 part of private companies. 8 Now we know that these ideas found their way 9 into the JOBS Act, but that doesn't in any way lessen 10 their importance or lessen the importance of your work in 11 advancing these issues before something is actually done. 12 In addition, we've made a recommendation regarding 13 scaled disclosure, which we think is a fairly important 14 one. And we'd like to see some action on that. Also 15 conflict minerals, you know expressing at least the 16 Committee's view of the need to focus on capital 17 formation and investor protection and not politics. 18 And lastly, tick size, which perhaps is a piece 19 of the puzzle or a part of the answer to reinvigorating 20 the markets for the smaller public companies. But 21 there's still much work to be done. Perhaps there's no 22 better example of that than the agenda that we have set 23 for today which is quite full. We will start the morning 24 with a presentation by the SEC staff on three recent rule 25 makings that will be very important for smaller 0010 1 businesses: the elimination of the general solicitation 2 ban; the Bad Actor disqualification provisions; and the 3 proposed new Regulation D and Form D requirements. 4 We'll then have a presentation by the Angel 5 Capital Association and its views on these rule makings. 6 And then in the afternoon we'll discuss the impact of 7 the JOBS Act, which was enacted, as you know, nearly a 8 year and a half ago and also new ideas for facilitating 9 capital formation. We'll start with a presentation by 10 Joel Trotter, now of Latham and Jeffrey Solomon of Cowen 11 and Company. And we'll also hear from John Borer who 12 will present some ideas for easing the capital 13 information process by expanding availability of Form S-3 14 to smaller public companies. Chris, I'll turn it over to 15 you. 16 MS. JACOBS: Thank you. We'd like to welcome 17 Chair White this morning. She was recently appointed in 18 April of 2013 by President Obama to serve as the 31st 19 chair of the SEC. She arrived at the SEC with decades of 20 experience as a federal prosecutor and securities lawyer. 21 Prior to serving as the chair of the SEC, Chair White 22 was the U.S. Attorney for the Southern District of New 23 York, the only woman to hold that position in the 200- 24 year plus history of the office. 25 And while her background in federal prosecution 0011 1 and securities fraud is deep and storied, she is now 2 facing challenges that broaden that range and expand her 3 reach and her legacy. She understands capital formation. 4 And when Stephen and I had the good fortune of meeting 5 Chair White for the first time, she made it clear that 6 she understood our challenges, that she had followed our 7 work and wanted to make a difference in our world of 8 small and emerging companies. So with that, I welcome 9 Chair White. 10 CHAIR WHITE: Thank you very much, Chris. I 11 appreciate it very much. And I also was very interested 12 in listening to your report. I think there are some to- 13 dos in there for me that I heard as well from both you 14 and Steve. It's good to be back with the Committee today. 15 I think when I was here last time back in May, I hadn't 16 been here all that long. I feel like I'm fully settled 17 in at this point. I do continue, though, to really 18 marvel at the scope and importance of the SEC's mission. 19 And I was very glad to hear of your sort of hundred 20 percent endorsement of the spectacular SEC staff which I 21 -- you know, I completely share. 22 I mean as you know, this agency shoulders 23 significant responsibility on behalf of investors in our 24 markets and we are really blessed with the staff that we 25 have. So I appreciate that endorsement from you folks as 0012 1 well. I also want to reiterate just how important this 2 Committee is and how important your recommendations are. 3 They help us tremendously in our efforts. I'm going 4 to talk a little more about that as I go through this. 5 So let me personally thank all of you for the 6 dedication you've shown to this Committee and the 7 contributions that you have made to helping us do our job 8 more effectively. The Committee's co-chairs, Steve 9 Graham and Chris Jacobs, deserve a special thank you, 10 which I extend for your leadership over the past two 11 years. I'd also like to single out but there are many 12 more as well. 13 But I thank SEC staff, Mauri Osheroff, and I 14 think I pronounced that right. I can pronounce no names, 15 as you know. Ted Yu and Johanna Losert, in particular, 16 for their work supporting the activities of this 17 Committee. And I'll thank Jonathan Ingram, who I know is 18 going to lead the presentation today, too because he's 19 right beside me. 20 As members of the Advisory Committee on Small 21 and Emerging Companies, you are in a unique position, 22 truly unique position, to help us with insight into the 23 challenges that these companies face in the capital 24 markets. And you've performed an absolutely invaluable 25 role. That is why -- and I guess I'm actually the 0013 1 deliverer of the news to the Committee. I'm very pleased 2 to say that the Commission has renewed this Committee for 3 another two years. No surprise at all, but I just want 4 to confirm that to the Committee. 5 And I look forward to continuing the dialogue 6 and receiving your insights and suggestions on how we can 7 continue to support, enhance our support of small and 8 emerging companies. As I mentioned at the last meeting, 9 I really welcome policy and debates and am committed to a 10 rulemaking process that insures, within the parameters 11 obviously, our overall mission that the SEC makes a 12 positive contribution to the success of small businesses. 13 We have as an agency an extraordinary amount of 14 work to do. But one of my very top priorities, like I 15 said this last time as well, is completing the 16 congressionally mandated rulemakings that we have on our 17 plate, including the JOBS Act mandates which are intended 18 to help small businesses in raising capital. And I think 19 to reiterate what I think Steve said, you know, you also 20 -- your contributions to that JOBS Act effort really 21 can't be overstated as well, I think. So just to pass 22 that along. 23 As you know, in July the Commission adopted 24 rules as mandated by Title II of the JOBS Act to lift the 25 ban on general solicitation in Rule 506 securities 0014 1 offerings. And we, as Steve mentioned, adopted rules to 2 disqualify securities offerings involving certain felons 3 and other bad actors from relying on Rule 506. These 4 adopted rules will be effective next week, and I'm very 5 interested to see how they will be used. 6 In connection with their effectiveness, the 7 staff will be closely monitoring and collecting data on 8 this new market to see how it in fact operates, observing 9 the practices issuers and market participants are using 10 and assessing whether and to what extent the changes in 11 the private offering market may lead to additional fraud 12 or not. And, as you know, at the same time these rules 13 were adopted, the Commission also proposed rules intended 14 to enhance its ability to evaluate the development of 15 this new market and to address concerns that may arise 16 once the ban is lifted. 17 And I know your agenda as you've mentioned, 18 obviously has a detail about a discussion and 19 presentations on both the adopted rules as well as the 20 rule proposal. The comment period for the proposal ends 21 next week, and I encourage you to comment on the 22 proposal, obviously very interested in that. I know you 23 also have a keen interest in the remaining JOBS Act 24 rulemakings. So you should know we're continuing to work 25 very diligently to get those rules done in a way that 0015 1 facilitates capital raising activities and addresses 2 investor protection concerns. 3 Again, I strongly encourage you to provide 4 feedback on all of our rule proposals, as the insights 5 and suggestions you provide really will help us to adopt 6 better rules. So I couldn't be more encouraging of that 7 and that effort. The JOBS Act, as you know, also 8 directed the Commission to conduct a study and to report 9 to Congress on decimalization, in particular the study 10 which was sent to Congress last year. It was to look at 11 how decimalization affected the number of IPOs and the 12 trading of small and mid-cap company securities. 13 And following your last meeting in February 14 where you approved recommendations regarding 15 decimalization, the Commission held, I think it was four 16 days later if I remember -- although I wasn't here yet 17 but I did follow it -- held a roundtable to discuss this 18 particular topic. Across the panels I think it's fair to 19 say that there was significant support for the Commission 20 to implement a pilot that would widen ticks for small and 21 medium capitalization companies, though some during the 22 roundtable expressed concern about the potential costs of 23 the wider ticks. 24 The Commission is now considering whether to 25 pursue such a pilot and its appropriate parameters as a 0016 1 means to gather data to help inform decisions in this 2 area. I realize that a pilot differs from the more- what I 3 would call- definitive approach advocated by the Committee 4 in its recommendations. But I just wanted to have you 5 rest assured that this is something that continues to 6 have our very close attention -- this entire area 7 frankly, but including my personal attention and 8 interest. 9 Of course we also as an agency remain focused 10 on a range of other important priorities from enforcing 11 our laws and examining firms to reviewing filings and 12 engaging in a lot of complex rulemaking. In doing all of 13 this we always keep in mind our tripartite mission, our 14 overall mission to protect investors, to maintain fair, 15 orderly and efficient markets and obviously to facilitate 16 capital formation. 17 And we're always open, indeed anxious, to 18 receiving ideas for how we can better serve the needs of 19 all investors and small and emerging companies in 20 particular. So I'll stop with that. You have a very 21 full agenda, but I want to just say thank you again for 22 all that you do and for all of your assistance. I look 23 forward to receiving your report on your meeting today 24 and to our continuing dialogues in the future. Thank you 25 for having me and thank you for being here. 0017 1 MR. GRAHAM: Thank you, Mary Jo. I would like 2 to introduce Keith Higgins. Keith is the new director of 3 the Division of Corporation Finance. Keith was appointed 4 by Chair White a couple of months ago. He joins the SEC 5 after practicing for many years at Ropes & Gray. Keith, 6 I'd like you to make a few remarks and then introduce 7 the staff at the table. Keith. 8 MR HIGGINS: Thank you, Steve, and thank you, 9 Chris. Welcome, good morning. And thank you, Chair 10 White. We appreciate the support that you've shown for 11 the Committee and its work. I'd like to welcome 12 everybody here and thank all of you for taking the time 13 to be with us here today. The very busy agenda that we 14 have ahead of us -- gee everybody is leaving. You sort 15 of know what the pecking order is here at the Commission 16 but that's all right. I won't take it personally. 17 We do have a busy agenda, so I want to be 18 brief. As Stephen mentioned, I'm still a relative 19 newcomer at the Commission, having been here for just a 20 little over two months. And this is the first time I've 21 had the pleasure of joining the Committee in its work. 22 However, both from my private practice experience as well 23 as the short time that I have been here at the 24 Commission, I've been able to observe the work of the 25 Committee and the importance of the Commission and the 0018 1 staff to have a group of individuals broad ranging across 2 a lot of different disciplines, industries, types of 3 interest, to be able to provide thoughtful advice and 4 recommendations, to the Commission and to the staff, about 5 ways in which we can address the interests and priorities 6 of smaller companies and emerging companies. 7 When the Committee was created back in 2011, 8 then Chairman Schapiro charged it with providing the 9 Commission with ideas on how to facilitate capital 10 formation in a way consistent with investor protection, 11 as the Chair mentioned. Stephen went over the 12 recommendations and many recommendations. It's amazing 13 what the committee has done in its brief two-year tenure: 14 The ban on general solicitation or eliminating it, the 15 modification that triggers for reporting, the development 16 of a new offering exemption modeled on Reg A, creation of 17 a separate U.S equity market to facilitate trading by 18 accredited investors. 19 Ideas for revising small reporting company 20 disclosures, scaling it back perhaps in ways that would 21 make it more or less burdensome for smaller companies and 22 allowing, as the Chair mentioned, smaller exchange listed 23 companies to take advantage of an increased trading tick 24 for their securities. 25 Obviously, as Stephen mentioned, many of these 0019 1 have found their way into the law. The JOBS Act picked 2 up quite a number of them, and I can tell you we've got 3 teams working right now on the JOBS Act rulemaking. And 4 as the Chair had mentioned, the two -- the crowdfunding 5 and Reg A+ proposals are on the front burner. So you 6 should expect to see something I think in the relatively 7 near future on those. 8 For me the real value of the Committee's work 9 is not, you know, the breadth of the recommendations but 10 the thoughtfulness with which you bring your ideas to the 11 Commission and to the staff to allow us to get a 12 perspective of how you see things that we can be doing 13 better to help small and emerging companies achieve the 14 goals of facilitating capital formation. So I'm 15 delighted, as the Chair mentioned, the Commission has 16 decided to approve the renewal of the Committee for 17 another two years, and so I look forward during my tenure 18 to working with you. 19 With that and before we start out I'd like to 20 introduce the other SEC staff members who are up here 21 with me. To my left are Johanna Losert, in the Office of 22 Small Business Policy, and Ted Yu who is one of my Senior 23 Special Counsels. To my right are Jonathan Ingram, who is 24 our Acting Chief Counsel, Karen Wiedemann, who is an 25 Attorney-Fellow in the Office of Small Business Policy, 0020 1 and Mauri Osheroff, who is the Director who oversees the 2 office. 3 Since your last meeting Gerry Laporte, who I'm 4 sure all of you knew, who had for many years been the 5 Chief of the Office of Small Business Policy, retired. 6 And we are in the process of filling his position. I 7 actually believe very strongly that the Office of Small 8 Business Policy is going to be a very interesting place 9 to be over the next several years. There's a lot on the 10 Commission's agenda between the Reg A+ the crowd- 11 funding, the general solicitation activities that are 12 going to require implementation, thoughtful 13 interpretations. And really I think it will be a place 14 where there'll be a lot of activity and it will be an 15 opportunity for someone who's looking for an exciting 16 challenge and has an interest in helping small and 17 emerging companies to take on a responsibility. 18 We are posting for the position. It will be 19 available on the website. I would urge you if you know 20 anybody who's looking for a gig in Washington -- I did it 21 after 30 years of private practice. I can tell you 22 firsthand it's been amazing so far. It's been a great 23 opportunity to be involved in trying to shape policy. I 24 mean I've spent a lot of time advising companies how to 25 comply with rules without thinking a lot about what those 0021 1 rules ought to be, although I obviously occasionally did. 2 This I think is an opportunity for someone who 3 really wants to do something and wants to have an impact 4 to come in. So we'll be interested in getting 5 applications from folks who want to make a difference. 6 And so I urge you to if you have any recommendations, let 7 us know. We'd be delighted to hear them. So with that, 8 I'd like to turn it back to Chris and Steve to start 9 today's meeting. 10 MR. GRAHAM: We will just turn it right back to 11 the table and let you guys proceed. 12 MR. INGRAM: Okay. Thank you. 13 MS. WIEDEMANN: Good morning. 14 MR. INGRAM: And thank you, Keith. Good 15 morning members of the Committee. This morning Karen and I are 16 going to discuss the three rulemakings that Chair White 17 mentioned just a bit ago, each of the rulemakings 18 related to Rule 506, and Regulation D and Form D. I want 19 to start today by discussing the amendments to Rule 506 20 that will permit issuers relying on the exemption to use 21 general solicitation. Karen is going to discuss amendments 22 to Rule 506 that will prohibit certain bad actors from 23 relying on the exemption. 24 Finally, I'll conclude by discussing the 25 proposed rules that the Commission issued that, if adopted, 0022 1 could enhance the Commission's ability to analyze the new 2 Rule 506 market that is expected to develop. 3 MS. WIEDEMANN: And you know this but I'll say 4 it, we're here as a resource for you. So while we've 5 planned a presentation with some time for Q&A, obviously 6 if you have questions as we go, please don't be shy. You 7 know, this will work out better for everyone I think if 8 we can make it more interactive. So if an issue comes up 9 as we're going, please just dive in and we'll try to 10 address it. 11 MR. INGRAM: I was just going to -- the views 12 that we express today are our own and don't necessarily 13 reflect the views of other staff members or the 14 Commission. I know that many of you -- 15 MR. HIGGINS: That's retroactive back to the 16 Chair. 17 MR. INGRAM: Yes. That is 18 retroactive, yes. I know that many of you are well 19 versed in Regulation D and in Form D, but I thought it 20 would be worthwhile to spend a couple of minutes 21 describing the relevant rule and form at issue. 22 Regulation D was adopted by the Commission in 1982 and 23 consists of three exempted rules, Rule 504, Rule 505, and 24 Rule 506. Each of the exemptions have conditions that 25 must be satisfied in order for the issuer to rely upon 0023 1 them, such as limitations on the amount of capital that 2 can be raised and the types of purchasers that can 3 participate in an offering. 4 Rule 506 is by far the most popular of the 5 exemptions under Regulation D, comprising 90 to 95 6 percent of all Regulation D offerings. In 2012, almost 7 $900 billion was reported as being raised in Rule 506 8 offerings. This compares to $1.2 trillion raised in 9 registered offerings. I'm going to quickly run through 10 the five conditions or elements of current Rule 506 which 11 I will refer to as Rule 506(b). 12 First, there is no dollar limit on an offering 13 amount in a Rule 506(c) offering. Second, purchasers in 14 a Rule 506(b) offering must be limited to accredited 15 investors, a concept that I'll discuss in just a bit and 16 up to 35 non-accredited investors who are sophisticated 17 persons. Rule 506 defines sophisticated persons as those 18 having such knowledge and experience in financial matters 19 that they can evaluate the merits and risks of the 20 transaction. 21 Third, in a Rule 506 offering certain 22 information must be delivered to non-accredited investors 23 before any sales in the securities. In contrast, there 24 are no requirements to deliver information to accredited 25 investors before a sale. Fourth, the use of general 0024 1 solicitation in a Rule 506(b) offering is prohibited. 2 Finally, securities sold in a Rule 506(b) offering 3 are restricted securities for purposes of resale. 4 Generally speaking, this means that if 5 securities are sold by a non-reporting company, they do 6 not become freely transferable for a period of one year. 7 A key factor in the popularity in Rule 506 is that 8 securities required in a Rule 506 offering have “covered 9 security” status under Section 18 of the Securities Act. 10 In a nutshell, states cannot require registration or 11 qualification of a transaction in covered securities. 12 This means that many issuers will choose to rely on Rule 13 506 rather than other Regulation D exemptions in order to 14 avoid state law registration issues. 15 Now I'd like to go over two key concepts under 16 Regulation D, the definitions of accredited investor and 17 general solicitation. The first key concept under 18 Regulation D is accredited investor status. In general, 19 accredited investors are institutional investors and 20 wealthy individuals that are presumed to be able to fend 21 for themselves. Natural persons can qualify as 22 accredited investors on the basis of income or net worth. 23 24 For income, an accredited investor is a person 25 who earned more than $200,000 or $300,000 together with a 0025 1 spouse in each of the prior two years and usually expects 2 the same for the current year. For net worth, an 3 accredited investor is a person who has a net worth over 4 $1 million excluding the value of that person's primary 5 residence. In addition, there's a long list of entities 6 that qualify as accredited investors under the 7 definition. 8 One thing to note about the definition of 9 accredited investor is the “reasonable belief” standard in 10 the definition. This means that a purchaser is deemed to 11 be an accredited investor if the issuer has a reasonable 12 belief that that is the case, even if it turns out that 13 the purchaser does not in fact meet the thresholds in a 14 definition. The second key concept in Regulation D is 15 general solicitation. While the term general 16 solicitation is not defined in Regulation D, Rule 502(c) of 17 Regulation D provides examples of general solicitation, 18 which include newspaper and magazine ads, communications 19 over television and radio, and seminars where the 20 attendees have been invited through general solicitation. 21 In addition, the staff has issued interpretative 22 letters in which we've indicated that there is deemed not 23 to be a general solicitation in various circumstances 24 where an issuer or a broker-dealer has a pre-existing 25 substantive relationship with the offerees. So that's a 0026 1 brief summary of Regulation D and Rule 506 as it exists 2 today, which takes us to the recent amendment to Rule 506 3 that was adopted by the Commission on July 10th and as 4 the chair indicated, will become effective on September 5 23rd. 6 Section 201(a) of the JOBS Act directs the 7 Commission to amend Rule 506 to permit general 8 solicitation in Rule 506 offerings provided that sales 9 are made only to accredited investors and issuers take 10 reasonable steps to verify accredited investor status 11 using such methods as determined by the Commission. The 12 Commission issued the proposing release to implement 13 Section 201(a) in August of 2012 and voted to adopt the 14 rule and amendments as proposed with one modification in 15 July of 2013. 16 There are at least four important things to 17 note about Rule 506(c). First, general solicitation is 18 permitted under Rule 506(c) with no restrictions on the 19 content or manner of the general solicitations. This 20 means that issuers may include general solicitation 21 materials on their publicly-accessible websites. 22 However, general solicitations under Rule 506(c) are 23 still subject to the antifraud provisions of the federal 24 securities laws. 25 Second, purchasers in Rule 506(c) offerings 0027 1 must be limited to accredited investors, but there is no 2 limit on the number of purchasers who are accredited 3 investors. Third, as I will discuss further, issuers 4 must take reasonable steps to verify the accredited 5 investor status of purchasers consistent with the 6 statutory directive in Section 201(a). 7 Finally, Rule 506(b), which I discussed earlier, 8 remains unchanged after adoption of the rule. So for an 9 issuer that does not wish to engage in general 10 solicitation, or does not wish to verify accredited 11 investor status, or wants to sell to non-accredited 12 investors who meet the sophistication requirements of 13 506(b), those options are all still available. 14 As in the case with Rule 506(b) offerings, 15 under Rule 506(c) there is no limit on the dollar amount 16 of the offering. There are no specific information 17 requirements because all purchasers must be accredited 18 investors. The securities are restricted securities for 19 purposes of resale, and the securities have covered 20 securities status under Securities Act Section 18. As 21 for verification, Rule 506(c) sets forth a principles- 22 based method for verification, which is a flexible facts 23 and circumstances test that requires an issuer to make an 24 objective determination as to whether the steps taken to 25 verify accredited investor status are reasonable in the 0028 1 context of a particular offering. 2 In addition, the Commission added in the 3 adopting release a nonexclusive list of verification 4 methods that issuers may use but are not required to if 5 they want greater certainty that they have satisfied the 6 verification required. For the principles-based method 7 the Commission stated in the adopting release that the 8 factors to consider under this method include the nature 9 of the purchaser and the type of accredited investor that 10 the purchaser claims to be, the amount and type of 11 information that the issuer has about the purchaser, and 12 the nature and the terms of the offering. 13 In addition to the principles-based method, in 14 response to a wide range of commenters, the Commission in 15 the adopting lease also provided a nonexclusive list of 16 methods that issuers may use to satisfy the verification 17 requirement. This nonexclusive list is intended to 18 supplement the principles-based framework, and issuers 19 are not required to use any of these methods. 20 The nonexclusive list only applies to 21 verification of purchasers who are natural persons. This 22 nonexclusive list of verification methods consists of 23 four methods. First, verification based on income, which 24 can be done by reviewing copies of any IRS form that 25 reports income. Second, verification based on net worth, 0029 1 which can be done by reviewing specific types of 2 documentation dated within the last three months, such as 3 bank statements, brokerage statements and credit reports. 4 Third, written confirmation from a registered 5 broker-dealer, a registered investment advisor, licensed 6 attorney, or certified public accountant as to a person's 7 accredited investor status and finally, certification by 8 persons who had invested in the issuer's 506(b) offering 9 as an accredited investor prior to the effectiveness of 10 the new Rule 506(c) and continued to be investors in the 11 issuer. 12 And finally, a quick note on Form D. Form D is 13 a filing that must be made no later than 15 days after 14 the first sale of securities in a Rule 506 offering, or 15 for that matter, in any Regulation D offering. Since 16 2008, Form D has been required to be filed electronically 17 on EDGAR, so Form Ds are readily accessible on the 18 Commission's website. 19 In connection with the amendments to Rule 506, 20 Form D was amended to add a Rule 506(c) check box, so 21 that issuers will indicate whether they are relying on 22 the Rule 506(c) exemption. In addition, the signature 23 block of Form D was amended to include a certification 24 that the offering is not disqualified from the reliance 25 on Rule 506 pursuant to new Rule 506(d). And speaking of 0030 1 disqualification, now would be a good time for me to turn 2 over to Karen to discuss the bad actors release. 3 MS. WIEDEMANN: Okay. The Bad Actor Rule is 4 something that we've talked to you about before, but I'll 5 rewind the tape a little bit and give a little bit of 6 background. As John mentioned, there were three 7 rulemakings that came out of the July 10th Commission 8 meeting, the 506(c) rules, bad actor, and a proposal for 9 Reg D and Form D amendments. And for the Chair they were 10 an important package that responded to some of the 11 statutory mandates that the Commission has been given and 12 also attempted to address some of the investor protection 13 concerns and information gathering concerns that we have. 14 Bad actor was part of that package, but it 15 actually has a longer history. It goes back to the Dodd- 16 Frank Act and was a mandate from July 2010 to add bad 17 actor disqualification rules to Rule 506. With the 18 adoption of Rule 506(c), we think that bad actor has 19 probably become even more significant than it was 20 originally envisioned to be. So the rule that was 21 adopted as I said, you've been briefed on it before. 22 The basic idea is that an offering will be 23 disqualified from reliance on Rule 506 if the issuer or 24 any other person that's sort of covered in a covered 25 relationship with the issuer, has some sort of 0031 1 disqualifying event in its past. And we can talk quickly 2 about what the list of covered people are and what the 3 triggering or disqualifying events consist of. 4 There is also a difference in treatment that we 5 can talk about between a preexisting disqualifying event, 6 so everything that's happened up until September 23rd 7 which is the effective date of the new rule, compared to 8 events that happened afterward. So as I mentioned, 9 offerings will be disqualified if the issuer or any 10 covered person has a disqualifying event. 11 The list of covered persons that issuers will 12 have to think about besides the issuer itself, its 13 predecessor if there are any, any affiliated issuers -- 14 there's a group of sort of control persons of the 15 issuer that are in the frame, so directors, executive 16 officers, general partners, managing members. The rule 17 also covers officers of the issuer who are actually 18 participating in the offering. That's a change from the 19 original proposal which would have covered all officers 20 of the issuer. 21 There was a concern that that might reach too 22 broadly with large and complex organizations that may 23 have quite a lot of officers who don’t have much to do 24 with the activities under Rule 506. And so the focus for 25 officers is only on those who were actually participating 0032 1 in the offering. The rule covers 20 percent beneficial 2 owners of the equity securities of the issuer measured on 3 the basis of total voting power. That's also a change 4 from the proposal which would have covered any holder of 5 at least 10 percent of any class of the issuer's equity. 6 Again, the concern was an attempt to avoid 7 possible over-breadth and focus really on the equity 8 holders who were in a meaningful position to influence 9 the policy and direction of the issuer. The rule covers 10 promoters as proposed. There was a new addition for 11 pooled investment fund issuers which constitute about a 12 third of the 506 offerings reported on Form D. For 13 pooled investment funds the rules cover the investment 14 manager, that is the investment advisor of the fund or 15 other investment manager of the fund and the principals 16 of that investment manager, so general partners, 17 directors, managing members and so on. 18 And finally, the rule also covers as proposed 19 anyone who solicited or who is compensated for soliciting 20 investors in the offerings in place of an agent, broker- 21 dealer, that sort of thing, as well as directors, 22 executive officers, general partners and officers who 23 participate in the offering of those compensated 24 solicitors. The triggering events were substantially as 25 proposed with one addition, one fairly significant 0033 1 addition. 2 So what will trigger disqualification: certain 3 kinds of criminal convictions, basically convictions in 4 connection with the purchase or sale of security, making 5 a false filing with the SEC or arising out of the conduct 6 of certain types of regulated financial intermediaries? 7 And for that rule we'll look back five years in the case 8 of the issuer and its predecessors and affiliated 9 issuers, 10 years in the case of every other covered 10 person. 11 Similarly, you'll be disqualified for any court 12 injunction or restraining order in connection with the 13 same events, that is purchase or sale of security, making 14 a false filing with the SEC arising out of the conduct of 15 certain financial intermediaries. The look back there is 16 five years, so the injunction or restraining order must 17 have been issued within the last five years and must 18 still be in effect at the time of the proposed offering 19 in order to trigger a disqualification. 20 The new provision that was mandated by the 21 Dodd-Frank Act is a set of disqualifying events for 22 orders of state and other federal regulators. So that 23 includes things like state securities regulators, state 24 insurance and banking regulators, as well as federal 25 banking regulators and the National Credit Union 0034 1 Administration. The Commission also added the CFTC, the 2 Commodity Futures Trading Commission to this list of 3 regulators, you know, taking the view generally that 4 their actions should be considered on par with these 5 other regulators in the financial sector. 6 So disqualification will be triggered if any 7 one of the regulators on that list bars someone from 8 associating with the regulated entity from engaging in 9 the business of securities, insurance or banking or 10 similar businesses. Disqualification will also be 11 triggered for any final order based on fraudulent, 12 manipulative or deceptive conduct. And again, for those 13 we’re looking back 10 years, so any such order entered within 14 10 years of the proposed offering would trigger 15 disqualification. 16 There are a couple of different categories of 17 SEC actions that will trigger disqualification. First, 18 disciplinary orders relating to brokers, dealers, 19 municipal securities dealers, investment advisors, 20 investment companies will generally trigger 21 disqualification. In addition, and this was a change 22 from the proposal, a Commission cease and desist order or 23 a subset of them will also trigger disqualification. 24 When our baseline rules, the Regulation A bad 25 actors qualification rules were originally adopted, the 0035 1 SEC didn't have cease and desist authority. And so those 2 rules never covered C and Ds. Now to take account of the 3 power that the SEC has in this area, certain cease and 4 desist orders will trigger disqualification, namely those 5 that are based on violations of scienter-based antifraud 6 provisions of the federal securities laws, so for 7 example, 10(b) and Rule 10b-5 or violations of Section 5 of 8 the Securities Act which is the basic registration 9 requirement that applies for most offerings. 10 And then to round it out, the last group 11 unchanged from the proposal, any issuer that's had a stop 12 order issued with respect to their registration statement 13 or an order which are in the Reg A exception or any 14 underwriter that's participated in such an offering. 15 Suspension or expulsion from an SRO such as FINRA will -- 16 or a ban from association with an SRO will also trigger 17 disqualification and lastly, U.S. Postal Service false 18 representation orders. 19 There is as proposed a reasonable care 20 exception provided in the rules so that if an issuer can 21 show that it didn't know and in the exercise of 22 reasonable care couldn't have known of the existence of 23 the disqualification, that it will not lose the 24 exemption. So that was proposed and broadly supported by 25 the commenters and was included in the Final Rule. And a 0036 1 key difference from the proposal is the distinction 2 between the treatment of disqualifying events that 3 happened before September 23rd, the effective date, and 4 qualifying events that happened afterward. 5 And remember we're focusing on the actual -- 6 not the underlying conduct but rather, you know, the 7 criminal conviction and the court order, the regulatory 8 order. That's the triggering event. So for any of those 9 that occurred before September 23, the consequence for 10 the issuer will be a disclosure requirement. They'll be 11 required to provide purchasers a reasonable time before 12 they purchase a description of the events, so that they 13 have that in hand before they make their investment 14 decision. 15 For events that occur after September 23 -- on 16 or after September 23rd I guess technically, 17 disqualification will arise. And then lastly as in the 18 proposal, there is a provision for waiver included in the 19 rule. And so for good cause shown, the Commission would 20 have the ability to waive disqualification if it should 21 arise. And with that I turn it over to John to talk a 22 little bit about their Reg D, Form D proposal. 23 MR. INGRAM: Thanks, Karen. Well, July 10th 24 was a pretty busy day around here because the Commission 25 wasn't done yet. The final action that they took that 0037 1 day was to approve the issuance of a proposing release on 2 Regulation D, Form D and Securities Act Rule 156. The 3 proposal is intended to enhance the Commission's ability 4 to assess developments in the private placement market in 5 light of the fact that the prohibition on general 6 solicitation will be lifted. 7 In particular, the proposal would improve the 8 Commission's ability to evaluate the development of 9 market practices in Rule 506 offerings and would address 10 certain concerns raised by investors related to issuers 11 engaging in general solicitation. As the Chair 12 mentioned, there is a 60-day comment period on the 13 proposals and the 60th day is this Friday. So I 14 encourage you if you haven't already to read the 15 proposing release and let us know what you think. I know 16 that we're probably bordering on information overload 17 here as far as our descriptions of the different adopting 18 releases and now the proposing release. 19 So on the proposing release what I'm going to 20 do is -- there were seven main components too. There 21 were some proposals that were set forth in the release 22 and I'm just going to tick through them one by one. 23 First, issuers that intend to engage in general 24 solicitation as part of the Rule 506(c) offering in 25 addition to the current requirements would be required to 0038 1 file Form D at least 15 calendar days before engaging 2 in general solicitation for the offering. The Commission 3 referred to this as the advance Form D filing 4 requirement. 5 Second, within 30 days of completing any Rule 6 506 offering -- so that would be with or without general 7 solicitation, issuers would be required to update the 8 information contained in Form D and indicate that the 9 offering had ended. This was referred to as the closing 10 Form D amendments. 11 Third, issuers would be required to provide 12 additional information in Form D to enable the Commission 13 to gather information on changes in the Rule 506 market 14 that could occur after the prohibition on general 15 solicitation is lifted. The additional information would 16 include things such as expanded information on the 17 issuer, the types of securities offered, the types of 18 general solicitation used, if any, and the methods used 19 to verify accredited investor status of investors. 20 Fourth, an issuer would be disqualified from 21 using the Rule 506(c) exemption in any new offering if 22 the issuer or its predecessor or affiliates did not 23 comply with the Form D filing requirements in a Rule 506 24 offering within the past five years. As proposed, the 25 disqualification would continue for one year beginning 0039 1 after all the required Form D filings are made. Issuers 2 would be able to rely on a cure period for a late Form D 3 filing and in certain circumstances could request a 4 waiver from the staff. 5 Fifth, issuers will be required to include 6 certain legends or cautionary statements in any written 7 general solicitation materials used in a Rule 506(c) 8 offering. The legends would be intended to inform 9 potential investors that the offering is limited to 10 accredited investors and that certain potential risks may 11 be associated with these offerings. In addition, if the 12 issuer is a private fund and includes information about 13 past performance in its written general solicitation 14 materials, it would be required to provide additional 15 information and materials to highlight the limitations on 16 the usefulness of this type of information. The issuer 17 would need to highlight the difficulty in comparing this 18 information with past information of other funds. 19 Sixth, issuers will be required to submit 20 written general solicitation materials to the Commission 21 through an intake page on the Commission's website. 22 Materials submitted in this manner would remain 23 confidential, would not be available to the general 24 public. As proposed, this requirement would be 25 temporary, expiring after two years. 0040 1 Finally, currently a Securities Act rule 2 provides guidance on when information and sales 3 literature by an investment company registered with the 4 Commission could be fraudulent or misleading for purposes 5 of the federal securities laws. Under the proposal, this 6 guidance would be extended to the sales literature of 7 private funds. Finally, the Commission also requested 8 comments on the definition of the accredited investor and 9 manner and content restrictions on the general 10 solicitation of private funds. 11 So that's a rundown of the proposing release. 12 If you liked or didn't like anything that you heard, I 13 strongly encourage you to submit a comment letter to the 14 Commission. If you have already submitted one, you are 15 not precluded from submitting an additional one. If you 16 liked things, we'd love to hear that you did. If you 17 don't like some of the things that I've mentioned, we'd 18 like to hear that as well. And it would be particularly 19 useful in those circumstances if you could provide us 20 with some alternatives that we could consider to those 21 proposals. 22 We're also very interested in gathering 23 information on the costs and benefits that each of these 24 proposals would involve. So to the extent that any of 25 you have information or can compile information with 0041 1 respect to that that would be very helpful as well. So 2 that concludes our discussions of the three rulemakings 3 from July. And we're happy to try to address any 4 questions that folks may have. 5 MR. GRAHAM: Comments, Catherine? 6 MS. MOTT: I'd like to start with a question. 7 For the -- under general solicitation you list seminars. 8 Are seminars defined as demo days and venture fairs? 9 MR. INGRAM: Well, we don't have a definition 10 of demo days in the rules. And in fact as I mentioned, 11 we don't have a definition of a general solicitation. We 12 do provide examples of what could constitute general 13 solicitation. And it's a difficult question to answer. 14 It's a facts and circumstances determination. I don't 15 think that we could give a bright line answer with 16 respect to that one. 17 MS. MOTT: If I may comment on that please? 18 There are thousands of demo days and venture fairs. And 19 many people are in the audience that are accredited 20 investors and unaccredited investors and media 21 professionals and things like that. This is something 22 that has been happening in the capital formation markets 23 for many, many years. And we have concern that a 506(b) 24 offering that is present at the demo day that it will 25 default to 506(c) by virtue of being now considered 0042 1 general solicitation. So maybe having some I guess 2 clarifications might be helpful for the entire 3 marketplace. 4 MR. HIGGINS: I understand. What's the 5 situation now? 6 MS. MOTT: The situation now is that venture 7 fairs and demo days people come in and present their 8 companies for, you know, basically what the company does, 9 and what they intend to do, how they intend to grow, and 10 that they're raising capital. And as matter of fact 11 here's how much they're raising. 12 MR. HIGGINS: But I guess my question is -- and 13 I'm sorry. Someone must have concluded it's not 14 currently a general solicitation, right, because if it 15 were that would violate the rule, right? 16 MS. MOTT: Say that again please. 17 MR. HIGGINS: Someone must have concluded that 18 demo days are not general solicitations, right? 19 Currently, because if they were, they wouldn't be 20 permitted under current 506. 21 MS. MOTT: That's correct. What we're 22 concerned about is 506(c) says that it is. 23 MR. ABSHURE: Actually on your first question, 24 no. Every state out there has venture capital days 25 promotions for equity investment. And every one of them 0043 1 violates the prohibition on general solicitation 2 advertising. But unfortunately because they are most 3 often sponsored by a state government agency or in effect 4 the governor's office, we just watch. I had to be honest 5 with you but, yeah, every one of those technically -- 6 every one of those violates existing rules. 7 MR. HIGGINS: Well, I guess only if it's an 8 offer of security. Listen, I think it's a hard -- it is 9 a hard question, right? And, you know, the joke would be 10 we'll get to a definition of general solicitation right 11 after we get -- after one on insider trading. And of 12 course there isn't one. I think it will be hard. And 13 we're open to ideas but I think it will be hard to come 14 up with a definition, a safe harbor for what's a general 15 solicitation and what's not, because it's one of those 16 very gray areas. 17 But we recognize the -- now the rule of course 18 allows -- I mean the good thing about the rule is that 19 you can do it. If it happens to be a general 20 solicitation, that's okay. That doesn't preclude a 21 company from raising -- but of course you've then elected 22 into the only accredited investor bucket as opposed to 23 more flexibility for other types of investors. 24 MS. MOTT: Correct. For the entrepreneur who 25 is raising capital, you know, he or she may default to 0044 1 that and not know it. And I know the legal community is 2 trying to figure this out, and I know the incubators are 3 trying to figure this out. I mean I received a couple 4 calls from our local incubators, and I can't answer those 5 questions for them yet. So I know that there's some 6 fuzziness around that issue right now. 7 MR. YADLEY: One of the advantages of Rule 8 506(c) -- and I applaud the Commission for doing a great 9 job. It took longer than people thought and but I think 10 the results are pretty good. The most important thing is 11 it focuses on who's purchasing. It doesn't mean this is 12 not an incredibly important issue, and it makes it very 13 difficult for practitioners when the client comes in and 14 says I met all these people at this fair and I didn't 15 know them but boy, they really want to invest. And you 16 get into all this, so that's an advantage. 17 Having gone slowly to adopt 506(c), I also urge 18 the Commission and the staff to go equally deliberately 19 with respect to the rule proposals which are very broad 20 reaching. And I think everyone understands the need for 21 the Commission to have good information to be able to 22 study what's happening. I mean how can you improve 23 capital formation unless you understand what people are 24 doing and why they're doing it? So the goals are 25 laudable but the amount of information that would be 0045 1 required under the new Form D goes pretty far and 2 probably farther than is needed for the stated purposes. 3 And just to pick up another area from Catherine 4 of uncertainty: an advance filing is more difficult than 5 it sounds because often a company however it's met 6 investors, whatever it's trying to do, 15 days in advance 7 is a long time to make a commitment. And particularly if 8 it turns out that you have defaulted into 506(c) land or 9 made an inadvertent general solicitation, by that point 10 15 days is 15 days in the past and you've now blown the 11 election. 12 And because you've used general solicitation, 13 you can't fall back on Section 482. And I don't think 14 that the Commission intends to inhibit people like that. 15 But it really does decrease your flexibility. So that's 16 something that's important. At the tail end of that the 17 closing filing, it's really not so easy to know when an 18 offering has concluded in many cases. It's also as much 19 as I love, as you did Keith, being a lawyer and being 20 able to advise clients, in a lot of these private deals 21 lawyers are not around to be consulting all the time. 22 So a small company, even a good sized company 23 that's well run, they're not focused on the SEC rules. 24 So they think they're doing everything right but it's too 25 late to make an advance filing. And once the offering 0046 1 is done, they're back to business. And, you know, they're 2 not necessarily consulting their lawyer. 3 And then just a comment on the content. There 4 are lots of things that, again, I don't think this is the 5 Commission's intent but requests for information just 6 about the fact that somebody is raising money, that's 7 often considered confidential, particularly if it turns 8 out that the offering is not successful and you've now 9 sort of told the world hey, we tried to raise money and 10 we couldn't. 11 I think people that I've spoken with and 12 certainly the American Bar Association Federal 13 Regulations Securities Committee, to name one, is working 14 very diligently to provide comments, including 15 suggestions for how to do it better -- probably will not 16 be there by next week although everybody is trying. So 17 please don't rush into adopting some of these proposals 18 out of pressure from third parties. Thanks. 19 MR. ABSHURE: If I could respond to a couple of 20 Greg's comments there, we'll start with the advance 21 filing. Part of the reason the states supported the 22 advance filing is just so we can answer the questions 23 that are asked of us by investors. We go out and we 24 encourage investors to do their research prior to making 25 an investment, plus we're going to as part of our 0047 1 investment charge, be scouring the internet looking at 2 offerings and things of that nature. Well, if the Form D 3 doesn't have to be filed until 15 days after the first 4 sale, one, we're not going to be able to answer any of 5 those questions asked by the investors because we're not 6 going to have any information on file. Two, 7 we're not going to be able to tell by looking at an 8 internet advertisement or going to a seminar, or seeing a 9 billboard, whether this is an entity that is actually 10 trying to comply with Form D requirements under 506(c) or 11 is skirting those. Now in terms of confidentiality -- 12 MR. YADLEY: If I can just comment on that -- and 13 I'm sure you're not expressing the view that your state 14 or any other state advises investors about what offerings 15 to invest in unless it’s a registered offering and your 16 state has a fair, just and equitable standard. Also, as 17 much as I believe in enforcement, with all those the 18 offerings that are made under Rule 506, $900 billion, 19 there's not enough enforcement people to be doing that. 20 I understand that it's a bad answer to say, you know, do 21 your own due diligence investor, but to get the 22 information 30 days earlier than you would, I'm just not 23 sure how much you're going to get. 24 MR. ABSHURE: Well, I wouldn't disagree with 25 the date, but at the same time if the investor calls me 0048 1 and says tell me about the officers and directors of this 2 corporation, tell me about the beneficial owners of this 3 corporation, tell me who the placement agents are that 4 are selling this offering, have you had any problems with 5 them, have there been any disciplinary actions, have 6 there been any complaints, what do you know, that's the 7 type of information we give them every day. Now that's 8 not the type of information that I'm going to be able to 9 give them if I don't have that Form D. 10 MR. HIGGINS: I guess I -- it sounds like we 11 have maybe a bit of a three bears' problem you know. The 12 papa bear says the form is too late and mama bear says 13 the form is too early, right? So maybe there's somewhere 14 between 15 days before and 15 days after first sale. 15 MR. ABSHURE: I think it's -- you know in terms 16 of 15 days before I don't need it. We're not going to 17 review it, it's not a qualification filing. We're 18 prohibited from making a qualification filing. It's just 19 that I think the filing date ought to be tied to the date 20 that first time you use public solicitation of general 21 advertisement. As an issuer, you can't go that far until 22 you've made that filing. So you're going to 23 know if you're engaged in general solicitation. You're 24 going to know if you put it on your lips. You're going 25 to know if you're going to a seminar. Well, in that case 0049 1 I want to make sure that the Form D is on file prior to 2 that time, or at least simultaneously so when I get a 3 call from an investor who's been to that and wants to 4 know who are these people, have you had any problems with 5 them, I at least can answer those questions. 6 If the Form D is one of the documents that 7 investors use to make an informed decision on whether or 8 not to invest, if we tell investors to do their due 9 diligence before they invest, well let's give them the 10 document before they invest. If the Form D is part of 11 that, then it needs to be part of the entire package of 12 information that is out there before they would make a 13 decision to purchase. 14 MR. YADLEY: I can't answer all the questions 15 you've raised, but one thing that I think is key to the 16 discussion is the Form D. Should it be part of the 17 offering materials on which an investor is relying? And 18 historically this was not why Regulation D had the Form 19 D. It was there for information gathering and statistical 20 purposes so it's -- 21 MR. ABSHURE: I mine every one that comes in. 22 I pull the beneficial owners, I pull the officers and 23 directors. I pull the broker-dealers, I pull the 24 consultants that are getting compensation. And I put 25 that in our database and I look to see who's selling what 0050 1 and who are associated with the bad guys, and I think 2 it's at the same time. 3 I mean consider a 506(b) offering where they 4 don't have to give you anything. So if I have an 5 investor call me at that time and he says hey, I've got 6 an offer here to buy X, Y, Z corporation, and what have 7 they given you? Nothing. Well, at least I'm going to be 8 able to go back to the Form D and say here's the officers 9 and directors, here's the beneficiary, here's the guys 10 that are calling the shots, here are the broker-dealers, 11 and here are the issues that I've had with them in the 12 past. 13 The other thing in considering the permit on 14 general solicitation without guidance, gives us a little 15 concern. And I understand that ship has sailed. And 16 part of that is because I don't think that the zealous 17 entrepreneurs understand that once you start general 18 solicitation in advertising, both in the 506 offering and 19 perhaps a crowdfunding offering, you're no longer an 20 entrepreneur that's calling your own shots. You are now 21 arguably the management of a corporation. 22 And I don't think they understand the 23 difference in the various state corporate laws that are 24 going to be applicable to them. And also I don't think 25 they understand the difference between advertising their 0051 1 product, or say advertising their securities sales and 2 that the securities fraud liability is going to attach to 3 that. With regard to the reasonable steps to verify, I 4 think all of us will agree that that problem is much more 5 acute with dealing in it with an individual than it is 6 with an entity. 7 The states support verification by a third 8 party. To be honest with you, the last thing in the world 9 that states want to see is a third party error, an 10 investor sending their tax returns to the issuer that's 11 trying to sell them an investment. We don't want to see 12 that happen. We would much rather see that verification 13 take place specifically by a broker-dealer, because with 14 the removal of that prohibition on general solicitation 15 advertising that means you can have direct sales from the 16 issuer to the investor. 17 That gets the broker-dealer back into the 18 equation, and then maybe we have a back door suitability 19 analysis. Maybe a little bit of due diligence or at 20 least a broker-dealer looking at that investment and 21 advising their client as far as whether or not it should 22 be appropriate for purchase. And then we're not -- we 23 support the disqualification provisions, but in our 24 experience if somebody is disqualified, they're going to 25 stay in the offering, they're just not going to sign 0052 1 their name on the Form D. But we still think it ought to 2 be there, because it gives us a little more of a hammer. 3 And the last thing I'll say is we're not 4 extremely happy with the lack of retroactive application. 5 While we agree that if a party has settled a late filing 6 violation, that that probably shouldn't kick them out in 7 terms of a retroactive application but if in January or 8 in July he was convicted of securities fraud, we think 9 that should. That's all. 10 MR. GRAHAM: Thank you, Heath. 11 MS. MOTT: I'm going to speak practically, and 12 I'm going to talk about what happens in the real world. 13 First of all, my angel group has been around for 10 14 years. We've invested in over 40 companies roughly 15 $23 million We have never used a broker-dealer. We 16 won't use a broker-dealer for deals, because they're 17 coming to sell us a deal. We're out proactively looking 18 for a good opportunity to invest in. So this idea of a 19 broker-dealer just how it plays in the marketplace, that 20 doesn't bode well for the marketplace. 21 By the way, I've never contacted my state 22 securities association. This is no offense intended, but 23 this is, we do our due diligence. We use the best 24 practices of the National Venture Capital Association, so 25 we behave a lot like venture capitalist. And we do our 0053 1 due diligence, and not only do we know where the people - 2 - we know the people on the board. We know the people's 3 neighbors that are on the board. I mean these are local 4 deals. We drive by, we look and see that their car is in 5 the parking lot, lights on. 6 I mean we actively coach and mentor. You know 7 these people because they're your neighbors. They are 8 part of your community. So I'm just speaking to what I'm 9 hearing here, and I'm thinking this is not how the 10 marketplace behaves. 11 MR. ABSHURE: Well, I think that what you're 12 speaking of is indicative of what the old private 13 placement marketplace used to be, where you had 14 investors, institutional investors, the 15 organizational investors that had the experience, the 16 expertise to look at a startup entity and realize okay, 17 I'm taking a look at their board of directors. I'm 18 taking a look at their business plan, I'm considering 19 their capital needs, I'm looking at their IT, I'm looking 20 at the competitive -- you know, the competition and 21 everything else. 22 That was historically the private placement 23 market, and things were wonderful. That's changed, 24 that's no longer the private -- with this, that is no 25 longer the private placement market. I'll be honest with 0054 1 you, you're not the investor I'm concerned about. The 2 investor I'm concerned about is the one that flicks on 3 his computer, and whoever has the slickest website can 4 sell directly to that person. I'm talking mom and pop, 5 grandma and grandpa retail investors. 6 And I think that was always our biggest issue 7 with changing and removing that general solicitation 8 prohibition, was because it moved the historical private 9 placement investor, you guys, which had the experience 10 and the expertise and the ability to absorb a loss. And 11 it moved that speculative illiquid investment over to 12 someone who doesn't have the expertise and who doesn't 13 have the ability to absorb loss. 14 MR. YADLEY: Both of you have touched on 15 something that is -- it's sort of a side issue but it's 16 one that's been fighting for air; that is not everybody 17 has access to the angel group and there are 18 nontraditional broker-dealers who are available for some 19 of these smaller offerings. One of the key 20 recommendations of the last 20 small business forums 21 sponsored by the SEC, as well as a recommendation of the 22 prior advisory committee on small business, was to have a 23 sort of limited type of broker-dealer, someone who would 24 be regulated but who would be able to assist companies 25 raising capital, not necessarily do all the suitability 0055 1 and have all the bells and whistles attached to 2 regulation of a traditional broker. 3 But particularly now because issuers are not 4 going to necessarily be selling only to their neighbors. 5 Frankly, I think there are lots of dangers with general 6 solicitation. Even though I have supported it for years, 7 it's a good thing. The focus ought to be on the 8 purchaser and it is, but having lots of investors in 9 your offering if you're an issuer and having people that 10 you don't know, are both bad things. A smaller number of 11 investors who you get to know you, who can be 12 counted on for your next offering is very important. 13 There are lots of mostly individuals out there 14 who have some knowledge about the company who are not 15 necessarily angels themselves, or if they are, they have 16 limited funds but know people who have funds who can 17 perform a great service for issuers. And I think that 18 this is something the staff has lots of information about 19 this. And I hope you will reconsider a focus on a private 20 placement broker. 21 MR. GRAHAM: Okay. Greg, well you have the 22 last comment for this session. We're going to take a 23 break now. I thank everyone for their thoughts. We are 24 going to break and reconvene at 11:00. And we will be 25 continuing this conversation. 0056 1 (A brief recess was taken.) 2 MR. GRAHAM: We're going to be continuing with 3 the discussion of the amendments to Regulation D. And we 4 once again thank the staff for giving us more context. 5 And thanks everyone for the discussion that we had in the 6 last session. I'd like to introduce David Verrill and 7 Marianne Hudson of the Angel Capital Association. They 8 will be speaking to us now about some of their views in 9 the amendments to Regulation D and perhaps some of their 10 views of the unintended consequences of the new rules. 11 Marianne is the Executive Director of ACA. And 12 for those of you who don't know, ACA is the professional 13 Alliance of Angel Investors and angel groups in North 14 America with 200 plus member groups representing 10,000 15 accredited investors. And I'm sure you can vouch for each 16 one of those 10,000 accredited investors. Marianne has 17 been involved with entrepreneurial education and 18 mentoring programs designed to insure that all 19 entrepreneurs develop sustainable innovative businesses. 20 David is the Chairman of the ACA. He has spent 21 a decade at MIT raising capital from industry and 22 facilitating technology transfer. And David is also the 23 founder and managing director of Hub Angel Investment 24 Group, an earlier stage investment group in Boston. 25 Marianne and David, thank you for joining us and you have 0057 1 the floor. 2 MR. VERRILL: Thank you very much. It's a 3 pleasure to be here. We've got a PowerPoint presentation 4 going on behind us. We view so many PowerPoint 5 presentations we thought we'd inflict a little bit of 6 pain on you to see what our world is like. I'm going to 7 run through a number of slides just to set the scene of 8 what the Angel Capital Association is and does, what our 9 member groups and members do as well, really how the 10 process works. So it really gets down into the weeds a 11 little bit about the practicality of angel investing and 12 as well as to let you know the scale and the scope of those 13 investments. 14 So the ACA's mission is to fuel the success of 15 angel groups and private investors who actively invest in 16 early stage companies. We very recently expanded our 17 mandate from angel groups to accredited investors, 18 accredited portals and accredited family offices. We are 19 the largest trade group for angels. We have members in 20 every single state in the United States and five 21 provinces that represent approximately 10,000 accredited 22 investors, and, yes, we've certified them several ways 23 which I'll talk about a little bit later. Thank you. 24 We do have a charitable partner in the Angel 25 Resource Institute. Their real focus is on educating 0058 1 angels and providing research about our $23 billion 2 industry. And Marianne will go through one of the sets 3 of data that they have put forward. Just to kind of take 4 a step back and give everybody a graphic on what the 5 fundraising life cycle is really like, and if you look at 6 this graphic here, you can see the line represents where 7 a company is with respect to its stage 8 On the far left is just the idea stage, a woman 9 in a garage, an idea and progressing through proof of 10 concept, product design, product development, 11 manufacturing and delivery. Those are roughly the stages 12 of a company's development. And just underneath the line 13 you can see the types of funding, and in the rectangles 14 are descriptions of the likely funding sources for that 15 stage of company. 16 So the founder typically will use credit cards 17 and other savings and methods of getting companies 18 started. He or she then might solicit friends and family 19 who may or may not be accredited investors to pitch in a 20 small amount of money. Usually the securities that are 21 provided at that stage are loosely defined. There's no 22 lawyer typically that's involved in that level of 23 activity. But as individual angels and angel groups 24 start to look at companies in the seed and startup stage, 25 which is really the critical point of getting a company 0059 1 out of the garage and into the marketplace, that's really 2 the role that we play and our members play within the 3 Angel Capital Association. 4 And then outside of that oval you can see seed 5 funds, venture funds and then institutional equity. And 6 loans and bonds are put there to make a point. The banks 7 don't participate in the funding life cycle of early 8 stage companies. There's no collateral for them to take 9 as bond. And so really the banks don't play much of a 10 role until the end of a company's life. Now having said 11 that, there are banks like Silicon Valley Bank, which is a 12 partner of ours, that do provide debt financing as a 13 company is growing, but certainly they need to have 14 revenue in the form of their collateral. 15 Now just to talk about the level of investment, 16 last year angel invested about $23 billion in about 17 66,000 companies. The VCs invested about $27 billion in 18 a far less number of companies. But just to give you the 19 relative scale of angel investing, we really just don't 20 get the notice or credit I don't think in the marketplace 21 for (a), the amount of capital that we're putting to work 22 and (b), the stage at which we're doing it. And in 23 comparison to private equity you can see the size of 24 private equity funds is nearly $350 billion. And for 25 those of you who are interested in the hedge fund world, 0060 1 that's approaching $2 trillion. 2 So we're small in terms of the amount of 3 capital, but there are two really strong benefits to what 4 we do. The first is the stage at which we invest. And 5 if you look at the first two columns, the left hand 6 columns on this graphic, those are the seed and early 7 stages of a life's company. And you can see that angels 8 really provide on the order of 90 percent of that 9 financing. And again, these are companies taking in 10 their first real capital from so- called sophisticated 11 investors. And just in those two categories, angels 12 funded nearly 47,000 companies in 2012, and VCs funded 13 less than 2,000. 14 So almost 25 times the number of companies are 15 being funded at their earliest stages by angels versus 16 our colleagues the VCs. And the real output of that can 17 be seen in the creation of jobs. Startups create a 18 tremendous number of jobs. Certainly when you're 19 starting a company you don't have 482 employees, you have 20 2, 3, 4, 5 or 6. But there are many of them and they're 21 a really important contributor to job creation. 22 This graphic is a little bit of an eye chart, 23 but it basically is U.S. Census Bureau data from 1977 to 24 2005, nearly a 30-year period of time. And it tracks the 25 number of small companies and the number of jobs that 0061 1 they create in that year. And there are two points to 2 note. One, certainly without these jobs there would be 3 unemployment a lot higher than it is today and over this 4 period of time. But secondly, the consistency of the 5 number of jobs created by startups is pretty amazing. 6 And it's even more interesting to note this 7 ends in 2005. Since 2005, the number of angel groups in 8 the United States has nearly doubled. So my suspicion is 9 that the blue lines on this chart continue to increase 10 with regularity. Now we're here today to talk about the 11 JOBS Act and how the SEC has provided some rulemaking to 12 it. We want to make sure that everybody in this room and 13 our friends in the SEC and the audience beyond knows 14 about the landscape that angels work within, the 15 statistics, the trends, how sophisticated we are, the 16 impact on startups and how we help the health of our 17 economy. 18 We're going to talk about the final Rule 19 506(c), reasonable steps to verify accredited investor 20 status, what that means for startups and angels, the rule 21 on Reg D Form D, Rule 156 and the accredited investor 22 definition. And Marianne and I are going to ham and egg 23 it a little bit here. I'm the ham, she's the eggs, so 24 we'll let her take this from here. 25 MS. HUDSON: I have to think about what that 0062 1 means. Thank you so much for including us on this agenda 2 today. We really appreciate it. And I personally want 3 to thank the staff of the SEC which has been really open 4 and accommodating to hearing us. And I think they really 5 have -- are really trying to do the right things, protect 6 the investors, help capital formation. And I really 7 appreciate what they do. As David said, I think we want 8 to just spend a little bit of time talking about the 9 angel investing area before we talk about the rules. So 10 I'll be going through that in just a little bit. 11 So this might be another way of, you know, 12 talking about the overall financial landscape from one of 13 the slides that David showed. But we've kind of looked 14 at five levels of equity capital right now. And 15 entrepreneurs don't necessarily follow all of these 16 steps, but what we often see is first the entrepreneur is 17 funding themselves with their credit cards, their 18 mortgages, “First National Bank of You.” 19 And then they might work with their friends and 20 family to support what they're doing. And as angels, we 21 want to see that the people who know and care about them 22 are going to support them as well, but that might be 23 equity, it might be something else. And then angel 24 investors will follow up that kind of investment. And 25 then sometimes the kinds of things that we're funding 0063 1 need venture capital for expansion. Sometimes we 2 continue that financing, and the company has the 3 financing that they need. But between those kinds of 4 investment, between the angels who might stay in multiple 5 rounds and/or venture capital, we can then get those 6 companies ready so that they can go become part of the 7 public market, usually through merger and acquisition. 8 This will show you some kind of continuing 9 statistics about angels and again, making the point that 10 in terms of startups and early stage companies, we're 11 funding the majority of those kinds of companies. So in 12 2012, not quite $23 billion is estimated to have come 13 from angel investors compared to not quite $27 billion from 14 the important expansion of venture capital with 67,000 15 deals during that time from angel investors and 3700 from 16 venture capital. And it looks like there's something 17 like 268,000 accredited angel investors across the 18 country. 19 Just to give you a sense, you know, a piece of 20 some really successful branding companies. So what you 21 have here is a set of companies that started off with 22 angel investing. A lot of them then were venture backed, 23 but these became kind of the companies that have created 24 the jobs and the innovations that have changed the 25 quality of people's lives across the country. Let me talk a 0064 1 little bit about who angel investors are. Obviously, they 2 fit the accredited investor definition. And for me they 3 also are the kind who invest in companies that are not 4 their family, kind of hard to separate from their friends 5 because we get to know those people. 6 But what we do see is that a lot of investors, 7 particularly the ones who belong to our angel groups, are 8 former entrepreneurs or who have exited their company and 9 then they're making angel investments -- might be becoming 10 entrepreneurs again. But a lot of them are also 11 corporate leaders and professionals. And again, we see 12 about almost 270,000 of them. 13 From a motivation standpoint, you know, a lot 14 of them are doing it of course to make a return, and they 15 understand the risks that are involved. But this is 16 their chance really to invest part of their investment 17 portfolio in stuff that really matters to them from a 18 non-financial standpoint. So this is a way for them to 19 help entrepreneurs to stay engaged to really help create 20 what I'm going to call cool companies in their 21 communities. It's sort of that's their way of giving 22 back. 23 And they really care about that, whether that's 24 in their community, maybe it's, you know, parts of 25 alumnae of their university or some other sector that 0065 1 they really care about. So you know, they're doing that 2 to network and learn, they do want to make a return, 3 they'd like to see that they're giving something back to 4 the economy. But of course in the end, they are looking 5 for a return. 6 As David said earlier, we have seen a growth in 7 angel groups, almost a four-fold increase over the last 8 14 years. It started off with less than a hundred angel 9 groups just as the century started, and we now have 10 almost about 400 angel groups across the country. And 11 that's the majority of who we represent. It's the 12 easiest set of folks to be able to describe. But I 13 should note that the vast majority of angel investment 14 doesn’t happen from angel groups, it happens from 15 individuals doing their own work in formal sets of 16 organizations who may or may not be sophisticated, and of 17 course those who are now working through some of the 18 accredited web platforms that David spoke about. 19 I'm going to be spending most of my time on 20 statistics, talking about angel groups, because they are 21 the ones that we know the best and have the most data 22 about, but I do want to make that important point about 23 how angel investors work. So if we do look at angel 24 groups, you know, we see that there is something like a 25 potential of 8.7 million accredited investors that have shown 0066 1 up in multiple reports, including the proposed SEC rules. 2 It looks like there's approaching 270,000 active angels, 3 and about 15,000 of those belong to the angel 4 groups that I'm going to be talking about. 5 They are the experienced kind of groups I think 6 Catherine Mott mentioned before, you know. They have a 7 lot of experience. A lot of them have been making 8 investments or are former entrepreneurs themselves. They 9 like to invest in what they know about and have 10 experience about, so that they can add value to the 11 entrepreneurs, help them grow, connect them to potential 12 funders, potential customers and those kinds of things. 13 And we really spend a lot of time on best 14 practices, so we actually do a lot education through the 15 Angel Capital Association, the Angel Resource Institute, 16 really one of the best practices in being an angel 17 investor. And learn how to find the right deals, how to 18 do due diligence -- I'm going to spend a lot of time on 19 that. What are the right kinds of terms for the deals and 20 really best valuation? 21 And one thing that's really fun about being an 22 angel investor is, since a lot of us are former 23 entrepreneurs, we really understand that for us to do well the 24 entrepreneur needs to do well. So we become kind of an 25 extra advocate and mentor for them. And then, you know, 0067 1 once we make the investment in the company, we spend a 2 lot of time. We're on the boards of those companies, or 3 we are observers for that. A lot of us then kind of 4 serve as seed level people for some time on the company 5 to help them move forward if they're missing a particular 6 capability. 7 And we also look at developing the kind of 8 relationships that they need for follow-on funding, be 9 that from other angels later on or from venture 10 capital and other types of private equity. And really 11 kind of the biggest movement for us is developing 12 relationships with corporations who might acquire some of 13 our companies and help kind of an early exit. 14 This is kind of a graphic of the overall 15 evaluation process that angel groups use. So what we're 16 seeing is, you know, an angel group is getting somewhere 17 between five and a hundred investment opportunities per 18 month. They are coming to them individually or through 19 their own website that they have to work from. They've 20 set up often a team of members of the group to do an 21 initial screening of the investment to make sure it kind 22 of fits with what that group is good at. 23 Is that what they know about, is it in the 24 community that they want to work in? Does the team have 25 kind of a beginning understanding of really their company 0068 1 and their background and how they can really grow value? 2 And if it passes that kind of screening, then they 3 will get in front of typically either a monthly or a 4 quarterly investment meeting where that entrepreneur will 5 have a chance in that room of just accredited investors 6 and the staff of that group to put out their presentation 7 and answer a lot of questions from the group. 8 Let the group kind of visit about what they 9 think are the merits or concerns they have about that and 10 then might come back for an additional meeting for those 11 who might be interested in learning a lot more about that 12 company, spending a couple of hours with them to ask 13 questions before they move through a formal due diligence 14 process. And then finally, some small set of those 15 organizations receive an investment with professional 16 terms, working with really some strong legal counsel to 17 make sure we've got those processes together. And then 18 it's really our job to support those companies. 19 It looks like based on the statistics that 20 we've seen that somewhere on the order of about 5 to 10 21 percent of the companies that come to an angel group end 22 up getting financing from the organizations. The others 23 might kind of stay with us for additional mentoring and 24 maybe connection to other angels and investors in a 25 community to work with those companies and perhaps 0069 1 support them later. 2 And I guess from an angel group standpoint, it 3 looks like the average size investment for the group 4 itself is about a quarter of a million dollars. That 5 might involve somewhere between 10 and 20 individual 6 investors who are supporting that particular company, 7 sometimes investing individually, sometimes forming a 8 single purpose LLC to invest in that company and often 9 then syndicating with others, 10 Then, you know, what's really important for us 11 is to make sure we're supporting the entrepreneur after 12 we make the investment. So I think I've mentioned a few 13 of these things before, but certainly as part of the 14 investment we want the information rights. We want to 15 know, you know, what's going on with the company. And we 16 actually have learned through research that when we 17 really monitor the company and we mentor them, they do 18 better. There's a lot more potential success for their 19 growth. 20 So we have really spent a lot of time, you know, focused 21 on working with them. 22 And there has even been a study by Harvard and 23 MIT that's really underscored the importance of having 24 angels involved in selecting and supporting the 25 entrepreneurs to help them grow that really increases the 0070 1 chance of success. 2 Finally, what I want to do is show you a couple 3 statistics about what we know about angel group 4 investment. This is through the HALO Report, which is 5 really designed to talk about the trends and what angel 6 group deals look like. It's not meant to describe the 7 size of the market, but just what the deals look like and 8 comparisons between regions and type of sectors. And 9 this is a report done by the Angel Resource Institute, 10 Silicon Valley Bank, and CB Insights which handles deals 11 that were involved. 12 So first, what we know over the last three years 13 is that the median size deal of an angel group round is 14 between half a million and $625,000 when just the angel 15 groups are involved. So that means typically you have 16 two or three or four angel groups involved within that 17 deal. So this is the amount that the issuer, the 18 entrepreneur has received. Sometimes we do co-invest 19 with venture capitals, so the green line along the top 20 shows what the median sizes are when angels co-invest 21 with venture capital. 22 From a pre-money valuation standpoint for 2012, 23 actually 2011 and what we know for the first half of 24 2013, the pre-money valuation on a median range is two 25 and a half million dollars. But we give you a range 0071 1 there from really very small and startup to as much as 2 over $6 million. But we do -- we are seeing that we are 3 seeing quite a range of differentiation between regions 4 and certainly sectors. So certainly a lot of the IT type 5 investments would be smaller. 6 We know that the majority of our investments 7 are really in the Internet, what I call IT and software 8 and healthcare. And when we say healthcare, we mostly 9 mean medical devices. And so, you know, more than two- 10 thirds of our investments are in Internet IT, healthcare 11 and mobile and telecom with a lot more growth coming in 12 clean tech. But then you'll see really quite a variety 13 of investments. And by dollars of investments, you can 14 see a similar distribution there, except you can see that 15 healthcare takes a bigger percentage of our investments, 16 showing that the investment size for the life science 17 investments that we're making are actually considerably 18 larger because that's what those companies need. 19 Finally, the thing I really like about angel 20 investing is that angels are everywhere across the 21 country. This gives you a distribution by number of 22 deals in 2012 in the data set that's in the HALO Report, 23 and it really shows that the investments were really 24 truly across the country and not necessarily just in the 25 traditional venture capital areas that you might see in 0072 1 say California and Boston, really everywhere. 2 And then the final point is this is showing the 3 returns of angels and angel groups conducted by academics 4 Robert Wiltbank at Willamette University and the Kauffman 5 Foundation. And this shows I believe more than 3200 6 investments by angel group investors mostly between 1995 7 and 2007. And what it really shows is the median size of 8 returns for these deals was 2.6 times the investment in 9 3 1/2 years, which roughly works out to an average IRR of 10 27 percent. 11 But the real point here is that median doesn't 12 mean much, and so we've gotten to learn that, you know, 13 there's a lot of risks involved in angel investment. We 14 knew that already, it was just good to have the 15 statistics behind it. And so we see that more than half 16 of the deals or 32 percent lose some or all of our money 17 and not quite 8 percent have a 10 times or more return on 18 investment. And that's where the majority of the return 19 in that 27 percent IRR comes from. 20 And so we've learned from this kind of work 21 that, angel investors need to make multiple 22 investments to protect their ability to have a return and 23 not have a loss. Through some of this we are not showing 24 the slides. We've also learned things about if we invest 25 in what we know, we increase our potential or chances of 0073 1 success often for the entrepreneur. And also if we 2 support them with mentoring and monitoring, that also 3 helps them. So with that, I'm going to turn things over 4 to David with that background to talk a little bit about 5 the rules. 6 MR. VERRILL: Thank you. So Jonathan and Karen 7 and colleagues did a great job of describing in detail 8 the different rules. But just to repeat them very 9 briefly, the so-called 506(b) quiet deals, these are the 10 deals that we've been doing all along. And we have been 11 self-certifying by questionnaire whether or not an angel 12 investor is indeed accredited. We do that in order for 13 them to become a member of our group. And then when we 14 make an investment, we yet again confirm accreditation to 15 the issuer that we are indeed accredited. 16 And there have been no other additional 17 verification requirements to date, and the issuer must 18 have reasonable belief that the investor is indeed 19 accredited and otherwise unaccredited. We're going to 20 get into a little bit of the detail here, but I wanted to 21 just sort of put forward where the friction is, where the 22 rub is in process. And, you know, angels like everybody 23 else are creatures of habit. They've been doing 24 something one way for a very long time. They've been 25 relatively successful at it. They don't use 0074 1 intermediaries. All of the work is done on their own. 2 They are mentors, they are board members. And 3 so they sort of feel as if it's their ecosystem. And 4 they participate in a number of activities in order to 5 contribute to that ecosystem, but also to generate deal 6 flow and understand which of the companies that are 7 presenting in business plan contests. And demo days are 8 the best, because that's part of the screening process. 9 You want to find the best companies, and you want to help 10 those companies be successful both with your time, your 11 energy, your expertise, your connections, and your money. 12 We had our annual conference in San Francisco 13 last year, and the SBIR brought I think it was 10 14 companies that they had funded through one of their 15 programs. It was amazing to see some of those companies, 16 they were some really interesting companies. That event 17 was 99.9 percent accredited investors. There were some 18 vendors there and some sponsors of the ACA who had 19 personnel who were not accredited investors. And it 20 would be a darned shame for that to be so strict of a 21 regulation that we would consider that a public forum and 22 subject to a 506(c) filing. 23 These events are critical sources of deal flow 24 for us. And we want to continue to do that. We don't 25 want to retire our members from participating in these 0075 1 activities, and I fear that some of them will have that 2 type of a response. The generally solicited offerings 3 state that all purchasers must be accredited investors. 4 The old Rule B allowed up to 35 non-accredited investors, 5 really does not apply to C. 6 And there are a number of questions, for 7 example, if a company had a previous round of financing 8 where it was a B filing and did have non-accredited 9 investors in that particular series of financing, what 10 happens if the next series of financing is generally 11 solicited? And what about friends and family? It could 12 effectively make it difficult for friends and family to 13 participate in these types of rounds. 14 The other point I'd like to make is that the 15 issuers must take additional reasonable steps to verify 16 that all purchasers are accredited. As I mentioned 17 earlier, thus far we've been using a check-the-box self- 18 certification questionnaire. I certainly would like to 19 see that continue. If there are additional questions 20 that we all think could be added to that to add to the 21 veracity of that questionnaire that would be a 22 preference. The suggestions that have been listed and as 23 noted, it's a non-exhaustive list of methods that could 24 be used to take reasonable steps to verify. 25 But, you know, anecdotally I talked with a 0076 1 dozen or so angels when the initial rulings came out. 2 And, you know, the responses range from, "I'll never be 3 an angel investor again if I have to give my accountants 4 documentation such that he or she will have to prove 5 verification" to "It's no big deal." But I think the 6 preponderance of people just didn't like the additional 7 friction in the marketplace. And I think that adds just 8 another potential of risks of losing very important 9 investors in the angel ecosystem. 10 And I think the issuers are going to need a 11 tremendous amount of education. Entrepreneurs are 12 focused on starting their company, raising money to get 13 that company's products into the market and being 14 successful. What they really can't be asked to do is be 15 held down by regulation and additional activities that 16 take away from really the primary importance. Now I 17 understand that with the advent of crowdfunding a whole 18 new kettle of -- can of worms is being opened up. And we 19 do need regulation to govern that. But I think the 20 business as usual activities that we've been doing really 21 need to be preserved as much as possible. 22 The next slide is again, a little bit of an eye 23 chart, but this points to the safe harbors that the SEC 24 has commented on. And I won't go through each one of 25 them, but I think our initial response and that of the 0077 1 marketplace was okay, well let's find a safe harbor that 2 will cover us. And I think that approach has waned in 3 terms of how the marketplace ought to respond. I really 4 think that the principles-based approach that's been put 5 forward needs to be the primary method that we hitch our 6 wagons to. But I think we obviously need to define that 7 with far greater detail. 8 And to that point just a couple of bullets, and 9 Jonathan made note of these earlier as well. Whether the 10 steps taken as reasonable is an objective determination 11 in the context of the particular facts and circumstances 12 of each transaction, including the nature of the 13 purchaser, the type of accredited investor the purchaser 14 claims to be, amount and type of information the issuer 15 has about the purchaser, the nature of the offering, the 16 manner in which the purchaser was solicited, terms such 17 as minimum investment amount. The verification standard 18 requires the issuer to establish reasonable belief that the 19 purchaser is accredited. 20 And in some instances when a third party is 21 being asked to provide that additional reasonable belief 22 and verification, there's sort of a 30-day trigger on 23 that and also whether or not that needs to be done or a 24 three month -- was it a three month, three months. And 25 whether or not that would thereafter have to be three 0078 1 months every single time you make a new investment seems 2 a little bit much. 3 So the ACA has put forward guidance on the 4 principles-based method to our membership. We've shared 5 that letter of guidance with the SEC, and we have some 6 additional materials that we'll be putting forward to them 7 that show in far greater detail,I think, the positioning 8 that we think our membership will and should take. 9 The principles-based methodology certainly is 10 robust. We don't feel that people ought to be stuck in 11 the safe harbor treatment. But there are areas of shaded 12 gray I think that really need to be clarified. For us, 13 we believe that membership in an established angel group 14 called EAG here is a powerful mechanism of meeting the 15 principles-based methodology. We are all accredited 16 investors, we have certified that in order to become a 17 member of our angel group. 18 Almost all of the members of my group are 19 referred by another member. Word of mouth is a really 20 important method for us to sustain our angel groups. 21 Many of the members of my group have made investments 22 before joining an angel group, and the structure of the 23 group offers them a different mechanism of investing that 24 is appealing to them rather than doing it on their own. 25 They can share the expertise and the process that we 0079 1 bring to the way that our group works. 2 By the way, we are structured as a fund. Most 3 of the angel groups in the U.S. are networks where each 4 individual ultimately makes his or her own investment 5 decision and writes their own check. In my group, all of 6 the members of my group have committed to our fund, and 7 that capital has been committed. And then we will go 8 through the same process that Catherine's group or 9 Marianne's group goes through in order to find, screen, 10 present, perform due diligence, negotiate terms and 11 invest. We simply use a democratic approach for that. 12 But because we're structured as a fund, I think 13 there's a lot more rigor to the process. We're able to 14 preserve some capital from that fund to aggressively 15 follow our capital. Many of these companies need more 16 money than they even think, and multiple rounds of 17 financing are sort of the order of the day. So there are 18 different types of models amongst the angel groups that 19 shouldn't go unsaid. Almost all angel groups have a set 20 of conflict of interest guidelines. 21 Some of them even require their members to sign 22 a document on how they will conduct their business, how 23 they will report conflicts of interest. Ours does and we 24 take that very seriously. And if we have a person in our 25 group who does not behave accordingly to those rules, 0080 1 they're simply not invited into the next fund. In all 2 cases we're recommending that a deal that our members are 3 involved in 4 -- make sure that the issuer checks with their legal 5 counsel that they believe that membership in an 6 established angel group does indeed meet the principles- 7 based method. 8 We also think that the principles-based method 9 may be appropriate for other active angels and those that 10 might have invested previously, sat on public or private 11 boards. So these are other sort of litmus tests that 12 prove further their accreditation. So we'd like the SEC 13 for clarification, and we hope that they will consider 14 the discussion that we have here. 15 We would like to affirm that the ACA's guidance 16 on an established angel group as a reasonable principles- 17 based method, so that the market can develop practices 18 further and help capital formation more along the lines 19 with which we've been doing it. We don't want to upset 20 that applecart. 21 There are very common questions coming from the 22 entire ecosystem, not just angels and angel groups, about 23 general solicitation. And I think the word that's been 24 put into the rulings was seminars. And obviously we'd 25 like to know if demo days and other types of events are 0081 1 indeed considered public advertising, or if they're 2 really more an artifact of the process of a company 3 finding mentors, finding opportunities, to network with 4 people and ultimately finding funding. 5 And how do 506 investments work if previous 6 rounds had been filed as Bs, or had unaccredited friends 7 and family type of investors? So I think there's some 8 room for clarification in those guidelines and those 9 rules. And hopefully we'll get there at some point in 10 the near future. 11 MS. HUDSON: Thanks and I think a discussion 12 among this group about those kinds of issues would be 13 particularly helpful. What I'd like to talk about a 14 little bit is -- are the proposed rules on Reg D, Form D 15 and Rule 156. And I completely understand the thought 16 behind this rule to really get data and understand what's 17 going on there. It just may be that startups have some 18 different issues when they're raising capital than other 19 parts of the capital formation chain. 20 So I think many startups and early stage 21 investors do think that a lot of the pieces of that 22 proposed rule could put a lot of startups out of 23 business, because they missed some of the filing 24 requirements and don't have the capital behind it to 25 continue if they trigger a penalty. And to talk about 0082 1 this a little bit, I guess what I'd really like to do is 2 talk a little bit about who these companies are and how 3 they raise capital and then I'll bring up a couple of 4 ideas. 5 So, you know, a lot of the startups that we're 6 investing in have no revenues at all or really low 7 revenues. They're certainly not profitable at that time. 8 They have very few employees. We're often seeing at the 9 angel group level even, you know, companies that really 10 are just kind of two people and they're looking for 11 capital to grow to five or six initially. They don't 12 have the kinds of resources of some other larger 13 companies that also fit within the 506 space. 14 Many of these entrepreneurs, you know, know a 15 lot about their industry, they've worked in businesses, 16 but this is the first time that they’re CEOS -- this is the 17 first time that they're raising capital. And in the 18 past, you know, they've been funded through themselves, 19 their family and friends, bootstrapping and other things 20 like that. So they're less familiar with these rules, 21 and they often really don’t have attorneys or, you know, 22 the kinds of attorneys that can really, I think, well, 23 advise them in this process. So in other words, they may 24 not have heard about this process. 25 And how they raise capital right now I think is 0083 1 also really relevant. So most of them are submitting to 2 us an executive summary and then later a business plan 3 with an ability for us to ask a lot of questions that 4 then moves into much deeper information. If we want to 5 go in to do due diligence with them, we'll get kind of 6 full binders for that. But starting off, it's executive 7 summaries and business plans. It's rarely a PPM and 8 almost never are we having involved a broker-dealer, any 9 other intermediary. It's really based directly on our own 10 relationships. 11 And frankly as an angel investor when I make an 12 investment, I want to make sure that all of my capital 13 goes to the entrepreneur so that they can grow. That's 14 kind of where I'm coming from. So having an intermediary 15 gets in the way of that. It's hard for them, you know, 16 to put some of the advanced information about them in an 17 advance Form D because they may not know the 18 investment terms upfront. A lot of times what happens is 19 that it gets negotiated with a lead investor, in an angel 20 group or a platform or otherwise. 21 So, and then, the lead investor will lead a team 22 to do extensive due diligence which can still change the 23 terms of the deal based on what we learned. They're 24 identifying their potential investors from who they 25 already know, from the angel group, a lot of referrals. 0084 1 But yes, they are doing a lot of these events and demo 2 days. It's a very important part of how they meet us and 3 we meet them. 4 Another key thing to know is as these startups 5 are getting started, they have one idea of what they want 6 the business model to be or what the product is or how 7 the product is going to be used. And in discussions with 8 sophisticated investors and just kind of thinking 9 themselves, they may change their business model and 10 their idea multiple times. And there's so many great 11 examples of, you know, big companies now that started off 12 with one idea and it turned into something else. 13 So it's going to be difficult for them up front 14 to really talk about their business model. They may 15 really have to, in this proposed setup, file multiple Form 16 Ds to be accurate about what the company is going to be 17 about. And they're going to, you know, currently answer 18 a lot of questions and inquiries in person, by email, be 19 it secure or not, to go through the due diligence 20 process. And right now a lot of them are not wanting to 21 publicly reveal how much they're raising for 22 competitive purposes, competitive protection reasons. 23 So with that background, I think our key 24 concerns right now is that at least for startups and very 25 small businesses, it really is a significant burden to 0085 1 look at the requirements that are in the proposed rules. 2 As we've mentioned a few times, the pitch events are a 3 long-standing practice for how they're doing deals. So 4 it sounds to us like they will be fitting into the 506(c) 5 general solicitation category. 6 And from our conversations so far, it sounds 7 like a lot of startups don't know about that. And a lot 8 of the people who hold these pitch events also don't 9 start that and may or may not advise the issuers 10 correctly if they're participating in these events again, 11 triggering an unintended consequence. If they do miss 12 their filings and the cure of the 30 days, you know, they 13 do lose the ability to raise cash for a year. 14 And with some of them having very little cash, 15 very little sales, they really don't have a way of 16 continuing. So they would go out of business or many of 17 them would. Many of them might have to file multiple 18 Form Ds because they keep changing their models. 19 The idea of the disclosures in the legends sound like a 20 great idea, but it might take away some of the 21 advertising opportunities -- the new ones that they could 22 take advantage of. For instance if they want to do a 23 tweet or something like that, the legends are actually 24 longer than an actual tweet. So you want to kind of 25 figure that out. 0086 1 And then I think, you know, providing all the 2 materials that they might want to do which some of them 3 might not understand all of the things that they need to 4 provide, but that's videos, it's PowerPoint, it's all 5 kinds of materials that will be difficult for the issuers 6 to provide. And I guess we also kind of wonder what the 7 technology is to be able to accept all of these materials 8 kind of in one place because it's a lot of stuff and in a 9 lot of different formats. 10 And the other piece for us is, you know, while 11 this is really about the issuer, this does add additional 12 risks for us as investors. It's already a very risky 13 type of investment for us. And if we're increasing the 14 risk that the entrepreneur might accidently break these 15 rules, or perhaps not take care of the verification 16 correctly, then they need to unwind from the investment 17 and that's additional risks for us. So it's some of our 18 members are actually already intending to not invest just 19 based on that increased risk, some but certainly not all. 20 So our recommendations for discussion among 21 this group really is we'd like to see the rules withdrawn 22 as they're proposed. But as I said when I started this, 23 you know, certainly we do understand the need for data in 24 understanding what's going on with this huge change to 25 capital raising. 0087 1 So if you're working on a redeveloped proposal, 2 the couple things we think are important is to remove the 3 harsh penalties for noncompliance when it's accidental, 4 you know, not requiring an advance Form D, requiring the 5 legends and disclosures only when the terms of the 6 investment are communicated and also thinking about other 7 ways you might collect some of that data. There's groups 8 like this and other advisory groups that I think the 9 Commission could work with to get some of that data and 10 reports in monitoring to get that information without the 11 additional burdens and penalties on the issuers. Turn to 12 the accredited investor definition. 13 MR. VERRILL: Thank you. Just very briefly, I 14 think the definition of accreditation has been noted a 15 couple of times today. But I just want to reiterate it 16 within the context that the SEC has been asked to revisit 17 this on a regular basis. And I want to make sure that we 18 all understand what the implications might be of changing 19 this in any dramatic way. So again, accreditation is an 20 individual whose net worth is above a million dollars, 21 not including that person's house, or through income of 22 $200,000 in each of the last two most recent years, with 23 a spouse $300,000. And that must be anticipated as being the 24 case in the current year as well. 25 The recommendation that the ACA has is to make 0088 1 no change in income or wealth thresholds for 2 accreditation. If there is the need for additional 3 questions added to the questionnaire to prove 4 sophistication, we think they're relatively -- there are 5 three really simple approaches to doing that. One, the 6 individual is a member in an angel group, which again, 7 provides another layer of proof of accreditation or some 8 other professional organization or angel platform. 9 Secondly, work experience if somebody has been 10 a director of a private or a public board, then certainly 11 they are a sophisticated business person and/or those 12 that have already made an investment under the existing 13 Rule 506. These are three very easy, reasonable 14 approaches to providing additional sophistication to the 15 questionnaire. 16 And I wanted to also indicate what the effect 17 of increasing the wealth threshold might have on the 18 existing group of accredited investors. This is a 19 graphic done by Wiltbank & Boeker based upon AIPP data, I 20 think it was commissioned by the Kauffman Foundation, 21 which essentially says that if you used inflation over 22 the past decade, what would that impact be if you 23 increased the accreditation threshold according to the 24 increase in inflation. Essentially it would double it to 25 $2 million as the net worth requirement. 0089 1 And the graphic shows that nearly 60 percent of 2 angel investors would not be accredited at that point, 3 so I think that's a scary number, and it points to the 4 fact that we're not all members of the Shark Tank show. 5 I know if any of you have seen that show, but they have 6 the misnomer of calling it a reality show. It does not 7 reflect an ounce of reality on how the angel world works, 8 and I do not have Warren Buffett in my angel group. 9 We're not the 1 percent. We are low-high net 10 worth individuals who have become very effective and 11 efficient at being angel investors. And indeed, the SEC 12 had put together some data reflected in the GAO report of 13 July of this year that showed a similar potential loss of 14 accredited investors should the threshold move from $1 15 million to $2.3 mil1ion. 16 So I think this is real. I think that this is 17 something we need to be careful of not pushing out a very 18 experienced set of savvy investors. I think it would be 19 catastrophic for the angel community. It would be 20 catastrophic for startups. There would be certainly half 21 as many startups created and certainly half as many jobs 22 and half as many chances for the next Starbucks. 23 And just to make a couple of observations about 24 the Dodd-Frank Act on these standards, there was a change 25 with Dodd-Frank. There was the removal of the investor's 0090 1 primary residence. And I think that was a relatively 2 significant change. And I think, to reiterate, that this 3 should be revisited under three circumstances to protect 4 investors, to be in the public interest and third, and 5 perhaps more importantly, in light of the economy. And I 6 think if we dramatically change the rules of 7 accreditation, we would harm our economy. 8 MS. HUDSON: Great. So just to, you know, wrap 9 things up, I think it is important to have that balance 10 of protecting investors but thinking about the economy. 11 And as David showed before, companies that are five years 12 or less create the net new jobs across this country. 13 These are the kinds of companies that angels and others 14 invest in, so we just want to remind you of that. 15 And what angels are really trying to do is help 16 those companies get the base, so that they get to their 17 next five years and these become the companies that 18 really explosively grow our economy and jobs, the Yahoos 19 and the Facebooks of the world are successful examples. 20 So we're really here to do that and to work with you to 21 figure how we meet all of the goals of these kinds of 22 regulations because they are important to us. And really 23 appreciate the time and we're here to answer questions or 24 be part of the dialogue. 25 MR. GRAHAM: Well, thank you, David. Thank 0091 1 you, Marianne. I think that was very helpful and it 2 certainly kind of gave me and probably most in the room a 3 greater appreciation for the role that the angel 4 community plays within the smaller company ecosystem. 5 Questions, comments? 6 MS. JACOBS: I have one. 7 MR. GRAHAM: Okay. 8 MS. JACOBS: Without speaking to the specifics 9 of your recommendations today, I think those of us in the 10 room that have maybe been through all those phases which 11 I have the good fortune of having been through that, not 12 the angel phase but the growth, one of the things we did 13 as our company -- it was a public company -- grew, was we 14 went on an M&A. 15 We went on an M&A streak and over on my watch 16 alone looked at 2100 medical device companies, okay. We 17 ended up buying four but over the course of those years - 18 - and when you talk about the lack of sophistication, I'd 19 like to echo that and say as we deliberate putting rules 20 into effect for a particular sector being an emerging 21 company, we really need to be careful. They are not 22 sophisticated. Just take the investing aside, you have 23 no clue what you will find when you go looking in their 24 books. And it's not intent to defraud. It's just lack 25 of sophistication. 0092 1 And I think this is the one area as we begin to 2 make rules -- throughout our two years, one thing we 3 noted from the folks at this table is that we have asked 4 for our regulators to recognize that one size does not 5 fit all. And I think this is one particular area, you 6 know, just “sans your specific recommendations." But 7 when you go looking at these 2100 companies and, you 8 know, their accounting is as creative as how they've 9 gotten to that point. But man, these are the job 10 creators. 11 And, you know, I can't tell you how many of 12 them we would sit there and as part of the M&A process -- 13 and these people have double digit growth in medical 14 devices. Well, the big companies are never going to get 15 it. And so this is tangential to what your issues are, 16 but it is the one size fits all issue for small and 17 emerging companies that we really need to step up and say 18 please be careful. We have enough challenges and hurdles 19 in front of us with these small companies. 20 So I'm not commenting on your specifics, I'm 21 just saying let's just take this whole scheme and say, 22 you know, please can we be careful that we don't strangle 23 this industry. 24 MR. GRAHAM: Well, I'd like to echo that a 25 little bit, Chris. I mean I don't -- I'm not speaking 0093 1 directly to your recommendations or maybe to the issues 2 specifically. But it seems to me that, you know, it's 3 clear when you look at the numbers, that the angel 4 community is very, very important to emerging companies. 5 I mean without the angel community there's $23 billion 6 at least that would not have been put into the system. 7 And so my sense is that the issues that have been raised 8 are real. I'm not sure what the answers are, but it does 9 seem to me that we need to be careful that whatever we do 10 does avoid harm, that whatever is done does avoid harm. 11 It seems to me that, you know, again this part 12 of the -- we're talking about the way -- we've spent a 13 lot of time talking about the way the markets are broken 14 and it's all for this reason, that reason, it's difficult 15 for smaller companies to raise capital and preserve 16 capital. This seems to be -- you know, one part of the 17 systems that's working. And nothing is perfect, but it 18 seems like this is one part of the system that is 19 working. 20 And so it seems to me that in that regard we 21 should kind of look for ways to kind of enhance the way 22 it functions and not to insert additional friction into 23 the way it functions. Again, don't know what the answers 24 are, but I think those are the kinds of things that we 25 need to think about. 0094 1 I mean I know all about these demo days and 2 fairs and all the rest. We have done similar things in 3 my own firm. And, you know, just that alone raises some 4 significant questions. And it could have a chilling 5 effect which could result in certain investments not 6 being made, and these things add up in terms of 7 investments not made, costs incurred, one job lost here, 8 one job lost there. Pretty soon you're talking about 9 real numbers. But in just that one situation for 10 example, that one scenario, you know the reason why we 11 started down this path to begin with in terms of 12 modifying 506 to permit general solicitation was the view 13 that the important thing was not how you got the 14 investor, but the important thing was the nature of the 15 investor. 16 And it seems to me that at least when we were 17 talking about certain demo days and fairs and that sort 18 of thing, maybe we shouldn't decide whether or not that 19 is or is not general solicitation. But maybe we can do 20 something which says that, you know, for purposes of 21 determining whether or not someone who gets accredited 22 investors by attending such an event, that they will not 23 be deemed to have violated the rule because they are 24 there and, you know, there a bunch of non-accredited 25 investors in the audience. 0095 1 So again, don't know what the answers are but I 2 do think that my sense is that the issues are real and 3 that we should find ways to enhance as opposed to ways 4 that cause friction. I mean obviously, investor 5 protection is something we never lose sight of. Yes, 6 Pravina please. 7 MS. RAGHAVAN: So I just actually wanted to -- 8 on the point of demo day I guess because you mentioned 9 SBIR. People in the SBA actually helped monitor and run 10 the SBIR program. And part of our mission and priorities 11 in the next -- actually even in the next coming months is 12 to have several demo days across the country for both 13 SBIR, as well as high growth entrepreneurs. 14 We just finished one right here at the White 15 House a month ago, so I would really take under 16 consideration that you will have quite a few of our 17 federal agencies participating in these demo days, 18 because it is a way of highlighting the high growth 19 entrepreneurship. And it's part of all of our 20 priorities, including I know my folks at the Department 21 of Commerce that are looking at the similar thing, to 22 actually highlight these high growth entrepreneurs across 23 the country and support them trying to find different 24 mechanisms. 25 So if we consider that general solicitation, I 0096 1 don't think any of us are in the -- we don't move them 2 into a category that they weren't considering being in, 3 especially for some unaccredited investors in there. And 4 the other thing I would say is we should really look at 5 the cost of verification. Having been with the high 6 growth firms for the past year and a half, the costs of 7 verification might actually just put them out of trying 8 to even raise capital in this market with the general 9 solicitation. 10 I understand their reason for looking for 11 accredited investors but having them bear the burden, I 12 think we need to look at the costs. These guys don't 13 have a lot of money as people have been -- well, as you 14 artfully said. It's a lot of credit cards, a lot of 15 friends and family, and it's something we should really 16 take into consideration not to increase the burden for 17 them to go ahead and get that capital. And we know that 18 they are the net job creators. We've seen a tremendous 19 amount of growth in them for the past year. 20 In fact one of our very big success stories is 21 Chobani Yogurt started off as a small little company in 22 upstate New York, and all of sudden now they are the 23 number one leading yogurt producer across the country. 24 So it would be terrible to see someone like that not be 25 able to get jobs into the market. 0097 1 MR. GRAHAM: Thank you. 2 MS. MOTT: I was just going to maybe piggyback 3 on what Christine was talking about, the fear of one size 4 fits all on two fronts. One is this could impact, you 5 know, the earliest -- let me say this first. Areas where 6 there is a very healthy ecosystem, San Francisco and 7 Boston, you'll find a lot of sophisticated attorneys and 8 accountants that can help these companies get off the 9 ground. And some of them do pro bono work because they 10 know they can’t afford it, or defer charges, things like 11 that. 12 But in other parts of the country where job 13 creation is more important than, you know, some of the 14 larger cities, you don't have that sophisticated law 15 firm. And you don't have that sophisticated accounting 16 beast. We experienced it ourselves when we put a smaller 17 chapter in a city north of Pittsburgh in Erie, 18 Pennsylvania. When we started talking with 19 entrepreneurs, they were -- the advice they were getting 20 from their attorneys and from their accountants actually 21 scared us, so you know, again for that one size fits all. 22 The other if I can speak to the accredited 23 investor status for one size fits all, I think the 24 previous recommendations according to the Dodd-Frank Act 25 was to raise the income from $200,000 a year to $450,000 0098 1 a year and from $1 million to $2.5 million. I will tell 2 you that in Pittsburgh, Pennsylvania, where I live, 3 making $200,000 a year is comparable to making $450,000 in New 4 York City. And if it was raised to $450,000, I will tell 5 you that the doctors that are in my group and the 6 attorneys in my group will be ruled out. They will not 7 be able to invest anymore. 8 And, you know, here in Washington, D.C., a home 9 that sells for $1 million probably sells for $250,000 to 10 $300,000 in Pittsburgh. So net worth is very different in 11 Pittsburgh as it is in so many other areas. So when we 12 think about this one size fits all, let's think about the 13 middle of the country, other parts of the country beyond 14 the big metropolitan areas and how those rules impact 15 those regions and particularly job creation for them. 16 Oh, and one other thing -- M&A. You couldn't 17 have said it better, Christine. Large companies do not 18 put the money into R&D that they used to, they don't get 19 the credits. There are other things that are happening 20 that they just don't do. They're not going to take the 21 risk and quite honestly they have become a culture that wants 22 to avoid risk. And so as a consequence, those cultures 23 don't cultivate new products, new drugs, new anything. 24 So what large companies find, it's better to let the 25 ecosystem create these small companies, take the risks. 0099 1 And the angel investors and the venture 2 community -- and that's how we get our exits and of 3 course that's how new products get delivered into the 4 marketplace. So a pretty critical component as we think 5 about one size fits all. 6 MR. GRAHAM: Thank you. Milton? 7 MR. CHANG: I have a slightly contrary view to 8 all of this. I think when it's not broken, don't fix it. 9 And I don't think over-regulated is better than under-regulated 10 to avoid problems and build a bad name for investing in 11 that kind of a deal. You now already have 35 exemptions, 12 35 unsophisticated investors on the rules. 13 So I think it's trying to make it easy up front, but make 14 it a lot more difficult back end, because dealing with 15 unsophisticated investor isn't funny either. 16 MR. GRAHAM: Please. 17 MR. ABSHURE: Skunk at the party, here I come. 18 And I realize everyone here is talking about concerns 19 over having an unsophisticated issuer and them getting 20 caught by the rules. But you've also got to remember 21 what we're talking about doing here is opening up the 22 doors of advertising and general solicitation to, as Mr. 23 Chang said, unsophisticated investors. And they're going 24 to be even less sophisticated than the unsophisticated 25 issuers that you're talking about. And I think that when 0100 1 you talk about allowing them to advertise and sell to the 2 public, that has to be reasonable. 3 And when you consider the speculative nature of 4 startup investments, the illiquid nature of startup 5 investments and the death rate of small companies, you've 6 got to figure out a way to balance the burden on that 7 issuer with the burden on educating and informing a small 8 investor. Now I understand concerns about the rules and 9 the proposed rules are problematic for, you know, 10 startups and they might get caught. If you are going to 11 take advantage of an exemption that allows you to 12 publicly sell and advertise your securities without 13 registration, learn the rules. 14 I mean to me we're talking about such a drastic 15 sea change in how we regulate securities that if a small 16 company wants to take advantage of that, learn what the 17 rules are. Now as I've said before, I think the SEC 18 should provide guidance. Startups don't have the 19 resources. They can't afford experienced lawyers, many 20 are raising capital for the first time, all of the 21 reasons that you need to give more information to an 22 unsophisticated investor, but those are also all the 23 reasons that the SEC needs to take a more active role in 24 reaching out to these entities and explaining what the 25 legal playing field is. 0101 1 And many startups will not be aware of rules 2 and accidentally break them. I don't know if there are 3 any enforcement people here, but I can tell you at the 4 Arkansas Securities Department that is an extremely 5 common defense. I get a whole lot of that one, "I didn't 6 know fraud was illegal." Now I'm not saying that that's 7 what we're talking about here, but that's what you're 8 going to get, a whole lot of I didn't understand the 9 rules and it wasn't there. 10 Now with concern to filing multiple Form Ds as 11 business models change, if I understand it correctly, 12 you're going to file a Form D if you have a material 13 change in the structure of your offering. I don't even 14 think filing additional Form Ds are going to be your 15 biggest issue. I think your biggest issue is going to be 16 determining whether you have just made a material change 17 in an ongoing offering of such a size it's going to 18 require you to go back and get confirmation from all your 19 previous investors that they want to stay in, or if 20 you've triggered rescission rights. And I think the 21 skunk shall be quiet at this point. 22 MR. GRAHAM: Okay, Heath. Thank you for that. 23 One thing is that you talked about unsophisticated 24 investors but it's -- we're talking about 506 and then 25 we're talking about often they're limited to accredited 0102 1 investors. 2 MR. ABSHURE: And my answer to that is if 3 anyone in this room thinks accreditation equals investor 4 sophistication, you're crazier than I am. 5 MR. GRAHAM: But that's the best system that we 6 currently have. 7 MR. ABSHURE: It's the best the system 8 currently has, and it's what we would have to work with. 9 I've given you an example that's very common. 10 MR. GRAHAM: You're going to have to give me 11 time, don't you understand that? 12 MR. ABSHURE: I understand that. I accept 13 that, I stipulate to that. 14 MR. GRAHAM: So you stipulate to the fact that 15 the accredited -- does not -- investor standard in no ways 16 measures sophistication or the ability of an investor to 17 do anything other than to absorb loss after a couple 18 hundred thousand dollars, and now we're going to 19 publicly advertise to that person. 20 MR. ABSHURE: I'm saying -- and I think we're 21 both -- so we’re both agreeing that that standard also 22 should be changed. 23 MR. YADLEY: Isn't the standard -- no, just to 24 break this up. By the way, he's right, sorry. We're 25 talking about disclosure and that's what the system is 0103 1 built on. And I'm -- my first job at the SEC was 2 enforcement. I believe in it, but you can't create a 3 system that assumes that people are going to be bad guys 4 and that everybody is out to defraud people. That 5 happens and that's unfortunate, and people lose money and 6 we need to do what we can to fix it. But you can't tilt 7 the playing field so far in that direction. 8 I'm from Florida. Florida has a private 9 placement exemption and it mirrors 506(b), okay. You can 10 have up to 35 unaccredited investors. And it has an 11 information requirement, and it says that you must do a 12 private placement memorandum or provide 31 specific items 13 of information. Florida does not have a Form D or any 14 other filing that talks about the offering. 15 I stipulate that Florida has had lots of fraud, 16 but not because there's not a Form D filing because 17 people don't make the information that they're supposed 18 to to investors. And it's in the law and the rules and 19 they're available. They're available on the state's 20 website which is easy, you just type what you want. So I 21 think that the focus is -- and you were talking about it 22 earlier and I'm not saying that Form D -- that we 23 shouldn't have a Form D. 24 But all the information that an investor needs 25 doesn't have to be in a Form D. I think rules that are 0104 1 clear about what needs to be provided -- and that's clear 2 in Regulation D now. No specific information 3 requirements except you look to what the appropriate 4 registration statement requirements would be if that 5 applies. 6 MR. ABSHURE: But if you're selling to 7 accredited investors, there's nothing. The Form D would 8 be it. 9 MR. YADLEY: And the theory is they can ask for 10 what they need. And I think the presentation today was 11 very instructive, and thank you both for doing that and 12 it was very lucid. Unfortunately, as your slides point 13 out, there are 265,000 angels and only 15,000 in groups. 14 So Heath isn't worried about you and your members and 15 your investors. And it's the other people out there, and 16 I get it. And so I think that's where a lot of our 17 discussion has to be and it's not one size fits all. 18 MR. ABSHURE: That's the one thing I would say 19 that I would agree that the one size doesn't fit all, 20 both with regard to the issuer and the investor and it's 21 the problem we're struggling with. 22 MR. GRAHAM: I want to make sure that everybody 23 has a chance, so Leroy. 24 MR. DENNIS: Oh. There we go. I have a 25 question along the same lines for Marianne and David and 0105 1 then I'll ramble a little bit to give you a chance to 2 think about it. And so the question is the $1 million 3 threshold, and $200,000 has been around for a while. 4 Do you think the sophistication of that investor has 5 increased over the years? And the reason I ask it, as I 6 listen to this I could see a train wreck coming. 7 If the sophistication is not improved so you 8 would say well, geez, you should index that for some kind 9 of inflation -- maybe it's not CPI but maybe it's growth 10 and income or something like that, so that you've got the 11 same investor investing that did 10 years ago that does 12 today, especially when I'm faced with a situation where 13 I've got a set of companies that now are less 14 sophisticated or less able to provide accurate 15 information. 16 So it becomes very important for that investor 17 to be able to sit across the table and ask critical 18 questions of that investee as to whether or not they can 19 -- so that make an informed investment. So absent 20 everything being the same you would say well, you should 21 index for inflation those accreditations. But, you know, 22 Internet, new world, new information, so I would think my 23 perception is that the sophistication of a person owning 24 a million dollars of investments 10 years ago -- let me 25 rephrase that. 0106 1 A person who owns a million dollars of 2 investments today is much more sophisticated than a 3 person that owns a million dollars in investments 10 4 years ago. And to me that's the reason why you wouldn't 5 change the accreditation rules along those lines. But 6 I'm curious what you guys see with your investor 7 community that you guys deal with. 8 MS. HUDSON: I think there are a lot more 9 people that hit those thresholds that are sophisticated 10 now than there were. So the proportion of people has 11 definitely increased, and that's come through the 12 Internet. It's come through a lot more information about 13 what angel investing is, a lot more dissemination of best 14 practices. Even, you know, 20 years ago I think the term 15 angel even wasn't that common. 16 And so people are starting to hear about that 17 and share that and do that through angel groups, through 18 certainly these investment platforms, the accredited 19 platforms. We're seeing a lot of dissemination of 20 information to the investors and to the issuers. So I 21 agree that a lot more of them are sophisticated. I guess 22 if I also build on that a little bit though, I also think 23 that perhaps originally when those thresholds were set, 24 they might have been set too high. And we might just be 25 getting to the level where they're correct as far as 0107 1 financials go. 2 MR. GRAHAM: David. 3 MR. VERRILL: Yeah. I don't really have 4 anything incremental to add. I think that's right on, 5 it's just the size of the angel ecosystem and the 6 mechanisms that accredited investors have to learn about 7 being an angel are just more prevalent. Our sister 8 organization ARI educates tens of thousands of people, 9 not just the members of our groups every year. And they 10 do that not just in this country but in others. I agree. 11 MR. BORER: Stephen, I don't think I've gotten 12 through a morning session in the last two years without 13 opening my mouth. First of all, I've been in the 14 investment banking and the private investment business 15 for a long time. And I must say that I've become far 16 more sophisticated through the money I've lost than from 17 the money I've gained. So for this to be something to 18 keep anybody from losing money and where we're better 19 off, obviously sophistication comes with age and some 20 amount of wisdom through learning. 21 When we had the discussion and made the 22 recommendation here at this committee, I think if I 23 recall correctly most of the discussion was around what 24 is the harm we're creating by advertising or soliciting a 25 broader audience if we maintain the level of investor 0108 1 qualification that we had previously. I don't recall 2 more than two or three minutes in that discussion 3 involving let's change the whole definition of who we can 4 go to if we're soliciting generally, and even come up 5 with a C instead of an A and a B. 6 What happened is through the JOBS Act, through 7 the implementation we've changed that pretty 8 dramatically. And I think a lot of this discussion is 9 around those particulars, either creating footfalls that 10 can take place, the landmines, various things that will 11 take place. And I must admit I'm not versed at all in 12 the angel investment communities. I probably qualify as 13 an angel, but I've lost more money than I've made. In 14 individual investments I've still got more than I started 15 with though. 16 One thing I'd like to make though -- because a 17 point I'd like to make is there were a couple of comments 18 here today that early stage companies, they don't need 19 broker-dealers and agents. And I absolutely agree. 20 Agents and broker-dealers do not want to in many cases 21 take those on. 22 But in the cases where the companies are far 23 enough along the development chain where agents and 24 broker-dealers may be helpful in the due diligence, in 25 the qualification, in putting a brand on a transaction 0109 1 that's getting done where it's not early stage, there are 2 certain requirements that are enhanced here under -- 3 where general solicitation is used with respect to 4 filings and those types of things. 5 FINRA put in place last year a series of 6 private placement filing requirements on the broker- 7 dealer community which I think intersect with some of 8 what's taking place here. And from my thought and some 9 of the discussion I've had with some of my peers, is 10 there may be a discouraging element of having a greater 11 level of disclosure if general solicitation is required, 12 because all those same things will have to be provided to 13 FINRA. 14 And to the point of is there even the 15 sophistication within FINRA of being able to accommodate 16 the intake of all of that, everything from links to 17 websites, all the content that may be on that website 18 that's hyperlinked, even if it's just in a tweet that 19 isn't big enough to contain all that information, et 20 cetera, I just wonder if there had been thought given to 21 that in the imposition of these requirements, the form 22 requirements and the filing requirements, and the content 23 with the FINRA requirements on the broker-dealer 24 community. 25 MR. GRAHAM: Thank you, John. We haven't heard 0110 1 from Richard. 2 MR. LEZA: On the part of increasing the levels 3 for sophisticated investors, let me give you an example 4 of what a difference eight years have made. I lived and 5 invested in the venture capital business in the Bay Area 6 for about 27 years. About eight years ago I retired, I 7 moved to Palm Springs. And in the Bay Area when you're 8 taking about sophisticated investors, you got a ton of 9 them. In Palm Springs when you're talking about 10 sophisticated investors, eight years ago you really 11 didn't have it. 12 But in eight years the kind of learning curve 13 that has increased in the number of people, that I think 14 it would be a mistake to increase the $1 million and 15 $200,000 up because you don't need to. You could really 16 go down, because people have become much more 17 sophisticated than before. So it seems to me that you 18 should leave the $1 million or the $200,000 where it 19 is. I think that's very significant. 20 MR. GRAHAM: Thank you, Richard. Kathleen. 21 MS. MCGOWAN: I agree with Richard on keeping 22 the threshold to where it is because of the 23 sophistication. But my one concern is something that 24 Christine brought up about going and looking at 2600 25 companies and the accounting. What are some of the 0111 1 accounting requirements that you have for some of your 2 investments that you make? Are they audited financials, 3 are there some sophistication in what they're reporting 4 and what they're saying is what their needs are and their 5 ability to project forward? 6 MR. VERRILL: Sure. Most of the documents that 7 we have in at closing are Series C financing or Series A 8 financing, have requirements of information rights that 9 often include financial information, particularly audit 10 on a regular basis. So yeah, they typically are. 11 MS. MCGOWAN: Mm-hmm. So I guess I think 12 what you were saying about some of the financials behind 13 some of the companies you were looking at. 14 MS. JACOBS: But I'm going to go back to 15 something that Catherine said. Audited financials out of 16 Philadelphia may not be the same as what we're going to 17 see out of Tucson, Arizona. 18 MS. MCGOWAN: Okay. 19 MS. JACOBS: And I'm from Atlanta. A lot of 20 these companies stated they had audited, but when you are 21 a public company buying a private company and the way 22 things have been accounted for and assets have been 23 identified, it's not always the same. 24 MS. MCGOWAN: It's not the same rigor that you 25 would have. 0112 1 MS. JACOBS: Yeah, exactly. 2 MS. MCGOWAN: Okay. 3 MS. JACOBS: And there's not fraud, it's not 4 bad intent. These guys have done their best given what 5 they could afford in their local markets. 6 MS. MCGOWAN: Right. Okay. Okay, thank you. 7 MR. GRAHAM: Tim. 8 MR. WALSH: Good morning. I'm going to ask a 9 non-accredited investor question or comments. It might 10 have been easier to ask these when the presentation was 11 going on, but the ying and the yang and the ham and the 12 eggs presentation was so smooth I didn't want to 13 interrupt. So just a couple of rapid fire questions. 14 The 15,000 investors in angel groups, so what is 15 that? And then a couple of times you mentioned angel 16 sites which sort of my ears went up when I heard that 17 too. What exactly -- these are Internets. You have to 18 have passwords I assume to be accredited investors. 19 And then the one thing that sort of jumped out 20 and there wasn't a page number on the presentation, we 21 talked about the returns from the angel sites. It seemed 22 very sort of data mining, 2700 data points over 12 to 13 23 years. Could you give a little more clarification on who 24 did this, why the 2700, how various investments are 25 thrown out or put in. 0113 1 And then lastly, I thought it was interesting 2 you mentioned the Kauffman Foundation was in some of the 3 charts in here. And I'm wondering if this was the same 4 article I read in the Kauffman Foundation maybe two years 5 ago when they were highly critical of the venture capital 6 industry. And maybe they were positive on the angel 7 industry, which I hope they were. 8 MR. VERRILL: I'll take the first two and give 9 you the last two. So the first question was the angels 10 within the groups that are members of the ACA. So my 11 group has -- we're structured as a fund. There are 40 12 people in that fund. Catherine, how many people are in 13 your group -- 65? Marianne, how many people are in your 14 two groups? 15 MS. HUDSON: One has 40 and one has 85. 16 MR. VERRILL: So rough order of magnitude there 17 are 50 to 100 people in every angel group, and 200 angel 18 groups are members of the ACA. That's where the number 19 of angels within our membership ecosystem comes from. 20 MS. HUDSON: And actually beyond. So we 21 collect data on any angel group that we know about. 22 MR. VERRILL: The second question was about 23 accredited portals and an example may be Angel List. 24 Angel List is a platform where you must (a), be referred 25 into and (b), show proof of accreditation. It's again, 0114 1 check a box. And then you can be on their platform where 2 they present deals that Catherine might have invested in 3 and because of her reputation, Marianne and I might look 4 at it even though we're not in that geography. We may 5 not ever have that company present to us. But based upon 6 the fact that Catherine and her reputation -- she's 7 invested in that company, we may choose to do it as well. 8 Angel List did submit a no-action letter to the 9 SEC which has made it into the safe harbor treatments 10 under the recent ruling. So they are I think the biggest 11 on the block but there are many, many, many other 12 accredited platforms lying in wait. 13 Some of them are sector focused and others of 14 them have different types of areas of focus. Some of 15 them offer different bells and whistles, but at the 16 end of the day, they are an effective mechanism for 17 anybody anywhere in the country to look at deals that 18 somebody else that has a reputation might suggest that 19 you want to invest as well. 20 MS. HUDSON: And maybe to follow up on that, 21 most of them have a process to accept them where not only 22 do they self-certify that they are accredited, but they 23 also have a process where they check with one or possibly 24 two members to confirm that they're accredited investors. 25 And most of them do require a password 0115 1 or something to look at the deals behind the scenes. 2 On your other questions, I'm hoping I'm getting 3 them right and for full disclosure, I am a former Kauffman 4 Foundation employee myself. And a lot of the work that 5 the Angel Capital Association does, and particularly the 6 Angel Resource Institute, is actually a spin out of the 7 Kauffman Foundation. So I think they did have a belief 8 in angel investing as a good way to support startups, 9 particularly geographically across the country. And the 10 focus was really on how do we make sure that more 11 investors are sophisticated and supporting those 12 investors. 13 As far as the study on the returns of angels 14 and groups, it was done in 2007. It was done by two 15 academics from Willamette University and the University 16 of Washington. They had a process where they wanted to 17 best collect these deals. I think it was closer to 3200 18 investments -- actually at exits with again, the majority 19 of the exits not being so good. 20 They wanted to be able to put in a process 21 where they would be able to generalize as much as they 22 could. So for I think it was six groups they will 23 collect all of the investments and exits it ever had. So 24 they made sure they got the good and bad and they 25 compared that then with other groups they may not have 0116 1 gotten full information on. But they wanted to make sure 2 there wasn't too much of a selection bias, in other words 3 there were not too many of the deals that were put in 4 that had a good result as opposed to a negative result. 5 And it was sent out to -- I'm going to get the 6 numbers wrong -- but more than 80 angel groups 7 participated in it. And more than -- I think it was 550 8 individual investors were part of that investment. And 9 then finally on other question, I think yes, the Kauffman 10 Foundation has put out a report on its own investments 11 and what that's meant for their returns with venture 12 capitalists. 13 I don't know much more about that study now, 14 but certainly they have been behind making sure that more 15 angels are sophisticated and they have the education 16 information that they need. Hopefully that answers your 17 question. 18 MR. GRAHAM: And Dan, I don't think we've heard 19 from you. Have you got something? Want to tell us about 20 your hike through Europe? 21 MR. CHACE: That would be interesting. I don't 22 have a lot to add. I mean this isn't necessarily where I 23 have any value to add, but it just strikes me that the 24 ongoing balance of investor protections versus capital 25 formation and which side do you come down on that. I 0117 1 think to me the most interesting question is the $1 million 2 threshold and the income are reasonable proxy for 3 sophistication. And I don't believe that it is, but I 4 also can't think of any other, you know, reasonable way 5 to define that. And maybe the ability to absorb a loss 6 is what's really relevant here versus your acumen as an 7 investor in startup companies. 8 So I don't feel that I have a lot to add, but 9 my bias would be to come down on the side of letting 10 people take risks within a regulatory structure that 11 provides information that's relevant. But you can't 12 protect everybody from everything. 13 MR. GRAHAM: Thank you, Dan. David and 14 Marianne, thank you very much. I think this has been 15 very interesting and useful. We're actually finishing a 16 minute early, so that qualifies as being on time. So 17 we're going to take a lunch break. The ideas for places 18 to have lunch, they're kind of listed in your folder. 19 And we'll reconvene promptly at 2:00. Thank you. 20 (A brief recess was taken.) 21 A F T E R N O O N S E S S I O N 22 MR. GRAHAM: Okay. Let's go ahead and get 23 started. It's -- we want to try to stay on schedule, and 24 this afternoon's schedule was to begin at 2:00, and it's 25 a little bit after 2:00. 0118 1 As you know, we're going to be spending this 2 afternoon talking about the JOBS Act, the impact the Act 3 has had on companies and markets after a year or so and 4 new ideas for capital formation. 5 We've got three speakers this afternoon. Two 6 have appeared. We're hopeful that the third will appear. 7 But we have with us right now Joel Trotter and Alex 8 Cohen, both of Latham & Watkins. 9 Joel is global Co-Chair of Latham's Public 10 Company Representation Practice, and he is the Deputy 11 Chair of the Corporate Department in D.C. As one of two 12 lawyers on the IPO Task Force, Joel played a leading role 13 in preparing a report to the Department of Treasury 14 addressing job creation by improving access to the 15 capital markets for emerging growth companies. Joel also 16 served as a principal author of the IPO-related 17 provisions of the JOBS Act. 18 Alex is Co-Chair of Latham's national office, 19 and his practice covers capital markets, registration and 20 reporting with the SEC and corporate governance. Alex 21 also served at the SEC, first as Deputy General Counsel 22 for Legal Policy and Administrative Practice, and later as 23 Deputy Chief of Staff of the SEC. 24 We also expect Jeffrey Solomon, who is the CEO 25 of Cowen and Company. I will go ahead and introduce him 0119 1 in his absence. Jeff is a director of the Cowen Group, 2 and he oversees all of Cowen and Company's business, 3 including investment banking and capital markets, sales 4 and trading and research. Now previously Jeff served as 5 Cowen's chief operating officer and head of investment 6 banking. He was with Republic, the New York securities 7 corporation, now part of the HSBC Group, and the Mergers 8 and Acquisitions Group at Shearson Lehman Brothers. 9 Jeff is also a member of the Committee on 10 Capital Markets Regulation, a research organization 11 dedicated to enhancing the competitiveness of the U.S. 12 capital markets, ensuring the stability of the U.S. 13 financial system. 14 So with that, I will turn it over to Alex and 15 Joel. 16 MR. COHEN: Well, Steve, thank you very much. 17 And I wanted to thank the entire Committee and the Chairs 18 and also the staff of the Division of Corporation Finance 19 for having us today. I think within Latham sometimes 20 people are a little tired about hearing us talk about 21 Title I because it's a topic that we really enjoy and 22 gets us excited. So we're awfully -- especially grateful 23 for the chance to talk about Title I to an audience of 24 people who are going to be -- I think share our passion 25 for it. 0120 1 As Steve already mentioned, Joel did play an 2 important role in drafting Title I, and I like to think 3 of him as James Madison whenever I have questions or 4 issues that come up about Title I. But what we thought 5 we would do today, if it would be useful for the 6 Committee, would be to go through an updated version of a 7 report that we put out in April which surveyed Title I 8 and looked into some data on what was happening and what 9 kind of accommodations, particularly, people were using. 10 And some of the data was, you know, to us kind of 11 surprising, and we'll talk about why that should be so. 12 MR. TROTTER: And just a note on how we -- the 13 methodology for the survey data. 14 MR. COHEN: Yeah, that's important. 15 MR. TROTTER: What we did was we started with 16 the universe of issuers that called themselves -- that 17 identified as emerging growth companies, and we excluded 18 from that universe the ones that were not listing or 19 expected to list on a national securities exchange. So 20 we basically looked at offerings by emerging growth 21 companies where they were either listing or reasonably 22 expected to list on a national securities exchange. So 23 that brought the universe of 500 emerging growth issuers 24 over the first year of the JOBS Act down to about 180, 25 184 issuers that were doing an IPO in that first year 0121 1 after April 5, 2012. 2 MR. COHEN: Yeah. We've included a copy of the 3 report in your materials, and it's online. But what was 4 -- one of the things that was interesting to us when we 5 started to bring down the data in order to prepare for 6 this meeting was that the trends that we had identified 7 in April were continuing. That was one of the first 8 takeaways, not because we had such a great crystal ball, 9 but I think more because a year's worth of time was 10 enough time to get a sense of how Title I was working in 11 practice and how people were using it. 12 So what did we find in the data? I mean one of 13 them was that -- you know, who are the EGCs? There have 14 been a lot of them actually. I mean it was really 15 striking to us, the take-up of Title I in IPOs. In fact, 16 I think we counted that about 85 percent of IPOs -- as we 17 put up in the slide -- since April have been by ECGs, the 18 companies that, as Joel said, self-identified as ECGs. 19 So it's certainly the case that Title I has -- 20 the people have been interested in following Title I or 21 at least call themselves EGCs, and it -- get some sense 22 for whether or not Title I scoped the world of EGCs 23 correctly, but it did pick up, you know, as we say, about 24 85 percent of IPOs. That's a high percentage. 25 MR. TROTTER: Well, a couple of things you can 0122 1 draw from this. One, it certainly changed the playbook 2 for the IPO process for all but the largest IPOs. And in 3 terms of opt-in by the emerging growth company 4 population, nearly all of them are using at least one of 5 the accommodations provided under Title I of the JOBS 6 Act. 7 MR. COHEN: And one piece of data which -- sort 8 of near and dear to my heart -- was that there were more 9 than 10 percent of EGCs who were foreign private issues. 10 It's near and dear to my heart because I spent a long 11 time in my career doing cross-border capital markets and 12 was, in fact, practicing in London for Latham when 13 Sarbanes-Oxley came out. And there was a period where it 14 was very difficult to persuade -- to make the argument 15 for non-U.S. companies to come to the U.S. capital 16 markets because they had, you know, various concerns, and 17 regulatory burden was one of them. 18 But to some degree Title I has been -- there 19 has been quite a deal of -- a good deal of interest in 20 Title I. We've made presentations to a number of 21 different securities regulators all over the world who 22 really wanted to know what Title I did and how the 23 decisions were made. So it's really kind of path- 24 breaking in that way. 25 Chart by industry. You know, Joel, we were 0123 1 talking about this earlier. I don't know -- I guess I 2 would have --before we had seen the data, I would have 3 thought that the technology line would be bigger. I was 4 struck that it was more broad-based than we would have 5 thought, you know. 6 MR. TROTTER: It's a good point. And if you -- 7 this chart has been updated since the one that's 8 reflected in our report, but the trend lines are the 9 same. So basically what you see is, on a percentage 10 basis, these are very much similarly proportioned from a 11 few months ago in April of this year when we did the 12 initial breakdown. 13 And one other thing about this, Alex, in 14 addition to what you just pointed out is I think there 15 was recent news coverage about the fact that -- or in -- 16 according to this story, technology offerings were 17 under-represented in the emerging growth company 18 population. And to me that was just -- it was yet 19 another instance of where you read something in a news 20 report, but when you look at the actual data after you 21 crunch the numbers, they tell a completely different 22 story, which is the preponderance of -- or certainly the 23 plurality of emerging growth company offerings. 24 If you're looking again at the sub-population 25 of offerings that are on a national securities exchange, 0124 1 they're mostly technology offerings. But then you have 2 it across all industries. It's not -- to Alex's point, 3 it's not that they're all technology offerings. It's 4 just that the greatest single slice is technology 5 companies. 6 MR. COHEN: You know, and I -- we didn't run 7 the data. I suspect there's something that -- you know, 8 Jeff, that your firm might know. But to me, just on a 9 kind of qualitative level, this looks like it maps 10 reasonably well to what you'd expect in an industry 11 breakdown for IPOs. It's a lot of technology companies, 12 which you'd expect, but also the other company mix -- 13 nothing really jumped out at me. Maybe there's more 14 financial services than I would have expected, but I 15 don't know if there's anything in this bar chart that 16 strikes you as out of proportion to the -- what you would 17 normally expect in the run of IPOs. 18 MR. SOLOMON: I actually think -- you know, I'm 19 not surprised about anything on here. I think the good 20 news is it's taking a while for people to get the word on 21 what it means to be classified as an EGC. So I think, 22 you know, in the days just following the JOBS Act, there 23 was a lot of debate and discussion about whether or not - 24 - if you were going to be an issuer that was labeled as 25 an EGC, you know, was that going to be a stigma. 0125 1 And I think -- so there was a lot of discussion 2 in and around some of these areas about whether or not 3 that was a negative thing. I don't hear that at all 4 anymore, so I actually think -- and I would say, once 5 companies go public, publicly traded investors, 6 institutional investors that we cover are not drawing 7 distinctions between EGCs and non-EGCs. So that to me is 8 more -- this kind of represents what I would think is a 9 good smattering, and it just happens to be the industries 10 that have embraced it most quickly. 11 MR. TROTTER: Jeff, you just mentioned the 12 stigma issue. I'll just throw out that was something 13 that when the task force was making its recommendations 14 prior to any of this becoming law, that was an issue that 15 was an area of focus for us, was how do we do this in a 16 way that creates meaningful change and doesn't just 17 create a small co. system. So we wanted changes that 18 would avoid that kind of stigma. 19 You see the 85 percent statistic that Alex 20 cited earlier. I think that's an important thing to bear 21 in mind, is from my personal standpoint it's a -- it's 22 right at the -- that's exactly what we would have liked 23 to see, basically changing the landscape broadly for all 24 but the very largest IPOs that don't need the assistance. 25 MR. COHEN: Yeah. 0126 1 MR. TROTTER: So if you're a large -- a very 2 large old industrial line company that's emerging from 3 bankruptcy, you can -- you don't need these 4 accommodations. Similarly, if you're a household name 5 major technology company, you don't necessarily need 6 these accommodations if you're over a certain revenue 7 threshold. You can debate what that was. And Congress, 8 at least last year, settled that debate for the moment. 9 But the billion dollar threshold for the 10 definition gives you a very broad meaningful category 11 that has a significant impact. At a billion dollars of 12 revenue, you're talking about a category of companies 13 that's roughly three percent of total market cap. So 14 it's not taking over -- relative to the size of the total 15 market, it's a small number. 16 Relative to the IPO market, it's a big number, 17 and that's where we were trying to -- that is the balance 18 that the IPO Task Force was trying to achieve in defining 19 the category the way that it was defined, but all of 20 which is -- you know, and Jeff mentioned the stigma 21 point. It was a significant policy issue. How do you do 22 this in a way that's tailored, that doesn't -- that isn't 23 over-broad but also avoids this issue of creating a 24 shadow system, a small co. system, a junior varsity 25 system that people are not going to want to use because 0127 1 of the stigma associated with them. 2 MR. COHEN: Well, you know, Joel, really to 3 that point, if you go ahead two slides to the breakdown 4 of revenue, it's really quite interesting, I think, that 5 nearly two-thirds of EGCs, as we put up there, have less 6 than $100 million in revenue. And then if you map to 7 less than $250, you pick up 80 percent of EGCs. 8 And so, you know, I -- there was a lot of 9 discussion when Title I came out, precisely on the point 10 about whether a billion dollars was an appropriate level, 11 was it too high, would it pick up too much. But it's 12 interesting that the EGCs have been, to such a large 13 extent, smaller cap companies. And it's -- really has 14 covered the lower end of the market in terms of cap -- in 15 terms of overall capitalization without, as I think 16 you've said, segregating in some kind of box really small 17 companies. 18 So it did achieve the trick of getting what 19 you'd think of conceptually as smaller companies without 20 confining you to a -- you know a small group of micro 21 caps. Put it that way. 22 MR. TROTTER: So I'll just address what I'm 23 imagining as a counterpoint to what Alex just said, which 24 is, "Okay, well, then why didn't you just set the bar at 25 $250 million in revenue." And there's – here is the point - 0128 1 - or the policy we're driving at is scaled regulation. 2 So it's not a one-size fits all transition period, right? 3 It's a period of up to five years depending on the size 4 of the company. And so you can go public as a $250 5 million revenue company and still have plenty of 6 additional time where you're going to enjoy the benefits 7 of these additional accommodations until you phase out. 8 So if you quickly become a really large 9 company, you're no longer -- you will no longer have 10 these benefits, or at the outer limit, even if you stay 11 at $250 million of revenue sort of indefinitely, the 12 phase-in ends after the year-end following the five-year 13 anniversary of your IPO. So you're really -- you're 14 limited to a five-year phase-in, but the extent of that 15 phase-in varies according to the size of the issuer. 16 And that's in contrast to some of the older 17 technology, right, under the securities laws where 18 everybody, regardless of their size had the same period. 19 You have until you're -- take, for example, SOX 404(b), 20 the internal controls audit. You have until the second 21 annual report that you file as a public company, at which 22 point it doesn't matter if you're a $10 billion revenue 23 company. It doesn't matter if you're $250 million. You 24 have to do SOX 404(b) compliance at that time under a 25 prior rule. 0129 1 So this, again, was something that we were 2 driving at in terms of a meaningful period of relief that 3 would scale according to the size of the issuer in a 4 meaningful way, not just at a transition period, which, 5 although definitely meaningful in the past, was really 6 kind of one-size-fits-all and pretty unforgiving for 7 smaller companies. 8 MR. COHEN: Well, one of the pieces of data we 9 looked at was which exchange just to see if there was any 10 you could map to listing on NASDAQ rather than the New 11 York Stock Exchange, which might have been one's initial 12 instinct. But it turns out that, in fact, it was quite 13 evenly distributed, slight edge to NASDAQ. But on the 14 two national securities exchanges, they were just about 15 50/50. And, again, I -- without having run the numbers, 16 I would imagine this is -- roughly correlates to overall 17 number of IPOs, non-EGCs and EGCs although not, of 18 course, by market cap where there -- you might see a 19 distinction. 20 So Title I accommodations, we thought -- we 21 assumed that people on the Committee are quite familiar 22 with what these accommodations are, so we won't summarize 23 them -- but obviously happy to do that if anyone were 24 interested. 25 But one of the things we -- questions we said 0130 1 for ourselves was, "Well, what's popular? You know, what 2 in Title I is popular? What have people used? What do 3 they use more of? What do they use less of," because we 4 all had ideas, I think when JOBS was passed, what might 5 prove to be popular or less popular. And to some degree 6 the results were kind of surprising. 7 And one that was, again, interesting to me 8 because of my experience over the years in the foreign 9 private issuer world was that the confidential submission 10 process was extremely popular. In fact, we counted that 11 almost 85 percent of EGCs used it. That number -- of 12 course, you can't tell the number of people who put it in 13 confidentially and never went through, so it may actually 14 undercount a little bit. 15 But it's a very simple idea, had always been 16 very popular for the foreign private issuer world because 17 it allowed people to get some degree of comment back and 18 forth without exposing their entire business plan to the 19 world. And it's -- you know, it's been one that people 20 really -- when you talk to issuers, our experience has 21 been that really -- potentially IPO candidates -- that 22 really speaks to them. It's also just interesting to see 23 how many rounds people go confidentially. It turns out 24 we count about two. 25 So they just submit a document, get comments 0131 1 back from Corp Fin, do another document and then go 2 public, which, Joel, I don't know when -- from the 3 Committee's perspective whether there was a concern about 4 people doing kind of the entire process sort of in secret 5 and then suddenly popping up with a fully baked document. 6 But it hasn't quite worked out that way it looks like. 7 MR. TROTTER: No, that's true. I mean on 8 average it's about 49 days from the first public filing 9 until the launch of the road show. And then the typical 10 timing is about 10 days after that to price the deal. So 11 people are not running right up to the line on the 21-day 12 requirement, but you know, even -- and with some of the 13 recent coverage about this procedure, even among some of 14 the critics, I've seen some commentary to the effect of, 15 you know, it is a meaningful benefit to these companies 16 to be able to do this without -- to initiate the process 17 without exposing their most competitively sensitive 18 information on the very front end of this process. 19 And the JOBS Act requirement of three weeks 20 prior to the road show, unveiling everything, including 21 the initial submissions in each amendment so everybody 22 can trace through the whole progression of the amendments 23 that resulted from the review process -- three weeks is - 24 - there was a pretty vocal critic in this area who was 25 recently writing about how three weeks is ample time to 0132 1 look over these filings if you're interested in figuring 2 out the back and forth and really studying the documents. 3 You've got a minimum of three weeks and, in practice, 4 over a month to do that. 5 And so, you know, this person was raising the - 6 - you could, I guess criticize this as too short, but 7 what meaningful benefit would you -- I mean at a certain 8 point you would need to -- if you believe in this 9 accommodation, you would need to cut it off somewhere 10 anyway. 11 The point was minimum 21 days on the theory 12 that that gives, in the information age with the 24-hour 13 news cycle and instant availability of all of this 14 information to anyone with a browser there is -- there is 15 plenty of time to look at everything that you want to 16 look at in three weeks. 17 MR. COHEN: Well, we also put up there 404(b), 18 the phase-in on 404(b) as well as the scaled CD&A have 19 achieved very, very broad acceptance. It's -- I'd say, 20 probably almost every EGC IPO has taken advantage of these 21 two. And to me what's interesting about the data is that 22 it does help inform the question about -- I mean I know 23 the committee has been considering scaling various kinds 24 of public company regulatory aspects. And this is at 25 least, I think, sort of market feedback as to what 0133 1 issuers find, you know, helpful and what they're less -- 2 you know, what they need less in terms of accommodations. 3 So 404(b) -- probably not surprising given the -- all of 4 the conversations about the internal control audit over 5 the years. But 404(b) is one of them. 6 But the CD&A is another. And I think if -- to 7 the extent that you're thinking about exec comp 8 disclosure, at least in the initial years as initial 9 filing as a public company extents of CD&A, people didn't 10 think that, I think, it was ultimately so critical for 11 the investment decision. There were other aspects that 12 investors were more focused on. 13 MR. TROTTER: Another continuing theme is just 14 that all of these accommodations are based on some 15 precedent in SEC policy or regulation. And here with the 16 streamlined executive compensation disclosure as an 17 example or the financial statement requirements -- those 18 are directly borrowed, of course, from the smaller 19 reporting company system where a similar policy judgment 20 has been made in a similar context; how do we offer 21 relief. How do we provide a tradeoff? 22 And so we were borrowing from a similar 23 tradeoff that had been made in a different context and -- 24 with the result that, you know, CD&A is not required for 25 emerging growth companies, and some of the additional 0134 1 financial statement disclosure is not required. 2 MR. COHEN: On this slide we talk about the 3 take-up of accommodations with respect to financial 4 statements. I have to say I actually found this 5 surprising because maybe it's just that three years of 6 financials is so deeply ingrained in my psyche it's hard 7 for me to imagine people going public on two. And I 8 think before -- 9 MR. TROTTER: But you don't represent a lot of 10 smaller -- 11 MR. COHEN: Well, that's true too. That does - 12 - it reflects my practice actually. But here -- and I 13 think in advance people would have predicted though that 14 three years -- investors are used to three years. They 15 would expect it. But there's been a fairly significant 16 take-up of it, not -- and I think not just in situations 17 -- there are obviously specific situations like in the 18 third year, a company's done a material acquisition and it 19 might be hard to find the financials, or the company's on 20 such an accelerated trajectory that, you know, in year 21 one they were just a couple of people in a garage and 22 then by year three, they are really a huge company. 23 But, you know, it was -- I think it's a trend 24 that not only we've observed but to some degree has sort 25 of increased. Initially it was relatively little take- 0135 1 up, but now it's stabilized at a certain relatively 2 healthy percentage, I'd say. 3 MR. TROTTER: One thing also that's noteworthy 4 is, even though most companies present the full three 5 years of audited financials, about one third of the 6 companies that do present the three years are taking a 7 pass on the selected financial data. So the additional - 8 - you know, years four and five they're not presenting. 9 So there is -- if you look at it very broadly, 10 there is wide scale acceptance of the financial statement 11 accommodation if you include selected financial data in 12 the presentation. 13 MR. COHEN: You know, that's, of course, not to 14 say that people are not diligent, say, in the out years. 15 I mean you wouldn't be surprised to know that that's an 16 important focus of activity. And, you know, it would be 17 -- you can imagine that, if there was an interesting 18 story to be told about an out year, you'd have a 19 different view about whether you'd include it or not in a 20 registration statement. But, you know, you're right that 21 some of the earlier selecteds are not appearing as well. 22 MR. TROTTER: And both in -- so for both those 23 and the material acquisitions above, say, 50 percent 24 significance were previously a company would have to go 25 to Corp Fin staff and get a waiver, part of doing their 0136 1 IPO, they no longer have to go through that kind of a 2 waiver process for these pretty far out years for 3 companies often that have limited operating history and 4 are growing at 30 percent. 5 MR. COHEN: And that's been an area -- it was 6 one of the areas where there were helpful interpretations 7 from the Corp Fin staff about -- particularly in the 305 8 area but, you know, on a wide variety of other things. 9 And, Keith, one of the things we did want to say was how 10 much we appreciated all the hard work of the Corp Fin 11 staff from the practicing and in getting out a huge 12 volume of interpretations in a short time. It made a 13 huge difference. 14 The -- another Title I accommodation is one we 15 -- the bullet point on the slide may be a little too 16 actually narrow because we said “Testing the Waters” was 17 deal-specific and industry-specific. And that has been 18 the case, but I think that's changing. I think “Testing 19 the Waters” is actually becoming a much more standard 20 feature of the playbook almost across industries. 21 It takes unlearning a lot of instincts to think 22 it's okay. I mean certainly I would -- all of my Section 23 5 antennae are twitching when people were talking about 24 it initially, and I think that's probably one of the 25 reasons why it's taken some time to gain acceptance, but 0137 1 it's gaining acceptance. I think that's pretty clear. 2 MR. CHACE: Question. 3 MR. COHEN: Yeah. 4 MR. CHACE: Just which, you know, types of 5 deals and which types of industries did you see take that 6 up initially? 7 MR. COHEN: Life Sciences was -- 8 MR. TROTTER: Yeah, and biotech -- 9 MR. COHEN: Biotech and life sciences. 10 MR. TROTTER: In biotech -- was almost 11 completely standard, those deals in particular. 12 MR. COHEN: Yeah. 13 MR. TROTTER: I think the buy side wants to 14 meet the management team. They want to understand the 15 technology in a more intimate way than a 40-minute 16 PowerPoint presentation on a road show can really permit. 17 So -- Jeff, do you want to add to that? 18 MR. SOLOMON: No question about it. And 19 actually it's interesting. You know, even as companies 20 are considering making confidential filings, they're 21 doing so so they can have a banter back and forth with 22 Corporation Finance. And actually all that's missing 23 from the public domain is just that banter back and 24 forth, right. And so by the time these companies are 25 getting out there, everything is already publicly 0138 1 disclosed that needs to be publicly disclosed, and 2 they've had substantive conversations in “Test the Waters” 3 that dovetails very nicely with "should we go or should 4 we not go". 5 And there are definitely times when we've been 6 through “Test the Waters,” especially in life sciences, 7 where we're saying, "You know what? Our recommendation 8 is not to go. And we got some feedback about this or 9 your strategy or this isn't resonating or that's going to 10 be a problem." And so not surprisingly, you're seeing 11 fewer -- in particular in life sciences -- fewer 12 companies actually priced below the range. 13 That's not foolproof. That still happens from 14 time to time, but it gives you -- even though we're not 15 discussing in that process valuation, we are gauging a 16 level of interest from investors, and we can give advice 17 to the company at that point very clearly about whether 18 or not now is the right time before they start to get out 19 on the road and end up in a situation where they spent a 20 ton of money and there's a lot of -- and there's lot of 21 deal expense and hung costs. 22 And I think the -- a lot of frustrations I've 23 heard from CEOs is, you know, "I'm in the middle of an 24 offering process. I didn't get a lot of transparency in 25 how that was going to go. It doesn't go well. I've 0139 1 spent all this money. I'm standing there with a -- an 2 only invested one-sided bet.” All the investors are 3 saying, “We got you so back up the truck, and I want to 4 buy this cheaper". 5 And so, you know, that was a very unhealthy 6 dynamic, especially in life sciences where you saw that a 7 lot. And now “Test the Waters” is actually -- you can 8 almost identify which of the investors are likely to be 9 anchors. That gives the existing investors, the existing 10 private companies and venture firms, a chance to think 11 about whether or not they want to be partners with these 12 people going forward. Are they going to put up more 13 capital at the -- at new issue? Is that going to be a 14 relevant investment decision? For them they know that 15 earlier so that they're not at the end scrambling around 16 and say, "Okay. We'll step out for a certain amount." 17 And what it's just allowed for is a lot more 18 balance and less stress in the offering process. I would 19 say, you know, the public offering process, especially in 20 IPO -- you're fitting 10 pounds of stuff in a 5 pound 21 bag. You have all these investors you got to see. You 22 get 30- to 45-minute meetings. Sometimes they're group 23 meetings. It's not a conducive environment for an 24 institutional investor to make a rational, thoughtful 25 investment decision. 0140 1 That's when the investment banks used to say to 2 me when I was in that seat -- they would say, "Okay. 3 We're pricing tomorrow. Are you in, or are you out?" 4 And I would be like, "I have like three more questions." 5 "Yeah, yeah. We hear you, but we need to know if you're 6 in or you're out." And I'm like, "I didn't get my 7 questions answered," and then I'm making an investment 8 decision with partial information, or I'm not 9 comfortable. 10 So if I'm in, I'm not really in. I'm in only 11 if it trades up, all right. And so -- and if it doesn't 12 trade up, I don't have enough information to know whether 13 or not I should stay in, so I start selling. It's a very 14 -- was a very, very unhealthy dynamic for small 15 companies. 16 And what we're seeing now is there's a balanced 17 thought. So when you're taking companies, there's a 18 higher probability around those offerings being 19 successful because there's been a discussion and a 20 discourse and setting expectations well in advance of an 21 offering. So a company can say, "Here are the benchmarks 22 I think we're likely to reach over the next 12 months." 23 And then when they come back for the offering, "We hit on 24 these three, we missed on these two, and here's why," 25 okay. 0141 1 It's just -- and so when it comes time for that 2 one week or two weeks to make an investment decision, 3 you're simply going out to a group of investors that's 4 well informed and you're not asking them at the end of 5 the day, "Are you in, or are you out? And you have to 6 make your decision by tomorrow with less than perfect 7 information." 8 So I think it's -- these two areas of Title I 9 have been game changers, especially in life sciences 10 where -- I mean let's face it -- even the best investors 11 have difficulty pronouncing the names of the drugs when 12 they're in clinic. It's that -- it's complex. And so I 13 always like to say most of the work in those companies -- 14 most of the fundamental investing work is done outside 15 the room. 16 There's the presentation, which is a half an 17 hour, 45 minutes, maybe an hour, and then there's hours 18 and hours spent fact-checking, talking to your scientific 19 reference people, you know, getting into -- getting 20 whatever information you can get to validate that and 21 look at all the competitive -- and look at the 22 competitive landscape. It's a lot of work. So it's 23 really helped out tremendously. 24 MR. COHEN: I'm putting Jeff down as the -- in 25 the fan column of “Testing the Waters.” 0142 1 MR. LEZA: Question. 2 MR. TROTTER: Yeah, please. And keep them 3 coming. We really -- you can tell I like this. 4 MR. LEZA: Thank you. As you keep going and 5 testing the waters, do you see the price range as more 6 and more companies will be able to hit in the price range 7 that they started off with? 8 MR. SOLOMON: I think the stats have said 9 that's the case. We were not allowed to talk about 10 valuation, and that's a tricky thing, you know. So -- 11 there there's definitely still games that go on in terms 12 of -- in investors' minds where they want to be included 13 in an offering, so they're always more positively 14 disposed to saying, "I want to see more," because as soon 15 as you say, "I'm not interested," then you stop getting 16 information. So where we've been learning is how to 17 gauge “Test the Waters.” 18 MR. TROTTER: And you can actually under the 19 law talk about valuation. But there are -- different 20 banks have different procedures along a continuum of sort 21 of prudential constraints, right? So where you draw the 22 line on what you discuss in your “Testing the Waters” 23 conversations can vary. And I think what you're saying, 24 Jeff, is a fair number of banks have drawn the line at 25 avoiding the valuation talk in the meetings. 0143 1 MR. SOLOMON: So this is a point of 2 clarification that should be -- I mean if there's a point 3 of clarification, it would be great follow-on. It would 4 be giving clear guidance on whether or not it's okay to 5 talk about pricing in “Test the Waters,” all right. 6 Because I'm not -- we've gotten guidance that, because we 7 don't have, that we just should not do it because then we 8 have Section 5 things we may be concerned about, so we 9 just don't talk about it. We're just gauging your level 10 of interest. If this company were to come, you know, 11 would you be interested? Would you be a participant? 12 How do you think about it? Is this an area where you'd 13 like to have some interest? 14 And so it's -- we're just having these 15 discussions now. As the IPO calendar has heated up 16 significantly, actually, there's just a contention on the 17 amount of time. And so we're seeing so many “Test the 18 Waters” meetings and so many IPOs that I actually -- I'm 19 wondering now, well, how much good information we're 20 getting from “Test the Waters.” 21 Interestingly, like early on when there wasn't 22 a lot of IPOs, we got a lot of great information because 23 a lot of people had a lot of time to spend and give you 24 good feedback. Now they're so busy looking at deals, 25 they're sort of like, "Yeah, I'm sure I'm interested," 0144 1 and that's not helpful. Like that's not a helpful thing. 2 So I think it's -- there will be an ebb and a 3 flow, but I would say we're definitely seeing, at least 4 to date, more companies coming in the range, and we're 5 able to really have substantive, sometimes difficult 6 conversations with issuers before pricing. 7 I had a conversation in the last week where it 8 was a tough conversation because the investors in the 9 company thought they were worth X, and the feedback we 10 got suggested that, if we were to go in that range, in a 11 range, that it was not going to be in that range. 12 MR. LEZA: It always starts there. 13 MR. SOLOMON: Yeah, it does. But in this 14 particular case it was pretty universal. It was pretty 15 universal. And so I sat down -- when I sat down with the 16 management, I'm like, "Look, here's the good news. I can 17 have a tough conversation with you now before you've rung 18 up all the expenses." And you're sitting there. You're 19 saying, "Oh my God. I'm so pregnant with this; I got to 20 go forward." 21 So you need to decide if you're willing to go 22 forward in this range. If you're not, we could talk 23 about alternative sources of financing and other 24 milestones that we can come back at this later on. But 25 now it's -- you know, thankfully you're not already 0145 1 pregnant with it, and you go in with both eyes open. So 2 -- 3 MR. TROTTER: And speaking of which, that goes 4 back to the confidential submission process -- 5 MR. SOLOMON: Yeah. 6 MR. TROTTER: And the benefit that that allows 7 for pre-IPO companies to combine the two and start 8 talking on a substantive level with institutional 9 investors long before they have initially submitted a 10 draft registration statement or even while their 11 registration statement is under review with the SEC 12 staff. 13 MR. SOLOMON: Right. So this is a company 14 that's -- you know, hasn't disclosed yet. It's gone 15 through the confidential filing. It's pretty much at the 16 end of that, and they're making sort of a go/no-go 17 decision. And when they decide not to go -- because our 18 best advice is to -- that the range that they were 19 thinking about isn't going to work, and so they may 20 decide not to go, in which case they're not tainted the 21 next time they decide to -- because they will come 22 eventually. I am a hundred percent convinced this 23 company will be a public company. It's just when -- 24 MR. GRAHAM: This is a great conversation, but 25 I want to make sure that Jeff has an opportunity to 0146 1 present his slides. 2 MR. COHEN: We were just thinking that, yeah. 3 We'll stop. 4 MR. GRAHAM: Okay. So -- and then see how much 5 time we have left so we can continue. 6 MR. SOLOMON: I don't want to cut you guys off. 7 So -- 8 MR. COHEN: No, that's quite all right. We'll 9 -- 10 MR. SOLOMON: Okay. Are you guys at kind of a 11 wrap-up point -- 12 MR. COHEN: Yeah. 13 MR. SOLOMON: -- because I don't want to cut 14 you off, either. That's -- No, no, no. That's quite all 15 right. You know the dangers of leaving us in front of an 16 open microphone. You can tell. 17 MR. SOLOMON: We all share that character 18 quality. 19 MR. COHEN: Maybe we'll just -- we'll leave it 20 on this slide and then turn it over to Jeff because we -- 21 you know, really this is, I know, the focus of some of 22 the things you want to talk about -- is what is to come. 23 We already covered the first point. We haven't talked 24 at all about research, but -- which is a complex topic 25 and would take up a whole hour. Just suffice it to say 0147 1 that research is not yet -- pre-deal research, immediate 2 post-deal research hasn't yet developed for a whole 3 variety of reasons. And, you know, we'll see what 4 happens in the future. 5 But Jeff, let's turn it over to you. I'll turn 6 this off. And you have a clicker. 7 MR. SOLOMON: Yeah. That would be great. 8 Thanks. 9 So real quick, I, first of all, what to say, 10 thank you. I mean I appreciate the opportunity to come 11 and spend some time and give you some real-time feedback, 12 as these guys have, on what's happening in the 13 marketplace. And I wanted to say to you I'm not -- I'm 14 here today not just as a person whose primary 15 responsibility is to run a firm that helps finance 16 emerging growth companies and small companies, but I'm 17 also a small capitalization company myself. So I'm a 18 named executive officer for a small cap company called 19 Cowen Group. 20 And so some of the things that we're going to 21 talk about today -- or I'm going to talk about today -- 22 are some of the challenges of being a public company that 23 does not meet EGC standards. And so we'll talk about the 24 JOBS Act and where it's been helpful, and I'll also give 25 you some insight as to some of the daily stresses that we 0148 1 deal with simply as a small cap stock. And we'll talk a 2 little bit about some areas where perhaps we can have 3 some improvement as well. 4 When I'm asked to discuss this stuff, like I 5 always start with the following premise, which is that a 6 positive environment for equity capital formation for 7 small companies fosters economic growth and advancement 8 in a number of ways. So jobs we talk a lot about but 9 also increased technology development and research 10 funding. And those are key tenets. So the dollars are 11 spent to get these companies public, and they're either 12 spent, you know, in the process of getting public or 13 spent in the process of developing the company. And for 14 a lot of these companies, that's a real decision; that's 15 a real economic decision. 16 I think that, if you look at the sum total of 17 what's happened in our country, if you just look at the 18 last century, you know, I think we did a really good job 19 at balancing the needs of investor protection and 20 creating a fair and balanced framework for regulation 21 that made it safe for investors to invest and also had 22 healthy capital formation. And I want to be clear. 23 People made money and lost money in the stock market. 24 And yet if you look at the sum total of just -- 25 if you invested in stocks post the '33 Act and '34 Act 0149 1 and you were a company that got formed in -- some of the 2 greatest companies the world has ever seen got actually 3 to where they were after the Securities and Exchange 4 Commission was created because there is this need to have 5 a balance between good regulation that protects investors 6 and regulation that fosters economic growth that doesn't 7 get in the way or impede it. 8 And so a little bit about what we're going to - 9 - we'll talk about this good. But if there is one 10 thought I would like you to leave with today, it's that 11 it's very possible to meet this dual mandate of 12 maintaining effective investor protections and fostering 13 economic activity. 14 And let's recognize the fact that there are 15 people and individuals and lobby groups on both sides 16 that will always advocate for less regulation and always 17 people that advocate for more regulation. And our job -- 18 I think the job of, you know, industry participants who 19 are balanced and thoughtful and this group is to try and 20 maintain that balance. And so as we talk about these 21 things today, there will always be points of view that we 22 should be factoring in, but we should be thinking about 23 the balance. And that's where the JOBS Act fits in. 24 So what's gone on with the JOBS Act is it 25 demonstrates in a new regulatory environment, a difficult 0150 1 regulatory environment in which the bar is much higher 2 than it used to be, that we can put forth regulation as a 3 -- and legislation as a country that fosters economic 4 growth and does not get in the way of all the valuable 5 investor protections we've set forth. 6 So a lot of people were opposed to this because 7 they were worried about it. I think there's probably 8 good reason why people were worried about it. And yet 9 we're seeing that the market activity afterwards has 10 actually been beneficial to individual investors and 11 institutional investors alike. And that's a really 12 important thought process as we go through this because 13 I'm going to spend a lot of my time on where we've been 14 effective with the JOBS Act though I think you've heard a 15 lot of this. And then where can we go from here is 16 really, I think, something I'm going to spend a little 17 bit more time on. 18 So I definitely think in general that, you 19 know, we did a great job for small private companies in 20 the JOBS Act, and that's been detailed. One area that 21 has not been addressed is existing public companies or 22 companies that were public already that would have 23 otherwise qualified or otherwise look and walk and talk 24 like EGCs but aren't characterized and so don't get any 25 benefits. By the way, Cowen Group is one of those. 0151 1 Just for frame of reference -- I didn't even 2 think about it. But one of the things I heard from a lot 3 of newly minted public companies that didn't meet the 4 deadline -- that kind of became public before the 5 deadline -- "if I had known this was going to happen, I 6 would have waited because now I have a structural 7 competitive disadvantage for all the people that do what 8 I do that came after that date" -- December 5th is the 9 date, right? Is that the date? 10 A PARTICIPANT: December 8, 2011, yeah. 11 MR. SOLOMON: "They have a structural -- they 12 have a cost advantage, and I don't." So that's -- it's 13 an interesting dynamic. Not that there's that many of 14 them, but there's enough of them that a lot of other 15 companies are saying, "Wait a minute. There's some 16 benefits here to characterizing yourself as an EGC, and 17 I'd like opt into that." So we'll talk a little bit 18 about that. 19 But I do think, again, when we talk about where 20 we go from here, there are a couple of key tenets I want 21 you to think through. One is how do we create and provide 22 trading liquidity in the secondary market? So if the 23 JOBS Act effectively is -- the analog to the JOBS Act 24 would be the '33 Act. What should we be doing to think 25 about things to make the existing public markets function 0152 1 more efficiently to induce capital formation? 2 One of them is trade and liquidity. And it's 3 not just like more trading. That's not the point here. 4 It's actually quality trading where -- can we provide an 5 environment in which fundamental buyers and sellers in 6 small companies -- I want to be really clear -- for small 7 companies -- can actually meet in a more rational, 8 simplistic market environment where real price discovery 9 works and where fundamental analysis matters more than 10 the speed of execution. 11 And I think we're talking about a very small 12 percentage of the marketplace. And we're -- on this 13 theme of one size does not fit all, if we can sort of 14 imagine small companies in and of themselves are really 15 like a protected class, we should be doing things to 16 foster maybe a different structure for them that promotes 17 a more healthy environment for capital formation. We can 18 talk about that in a little bit. 19 The second is, I think, you know, we have to do 20 that within this dual mandate of making sure that 21 investor protections are not squandered or we're not 22 going back to the way it used to be. And I think that's 23 a favorite refrain I hear from a lot of people that are 24 opposed to any change, you know, "We're not going back to 25 the way it used to be like in the '90s when a lot of bad 0153 1 stuff happened." 2 And I will just say I was -- I spent most of my 3 career as an investor not as a CEO of an investment bank. 4 So most of my career was spent looking at companies and 5 investing in them and putting capital to work. Like most 6 players in the marketplace, I did not have a good 7 experience at the end of the last century. I didn't like 8 that way the world was going. And so some of the changes 9 that have come into place -- I was a loud proponent for 10 them. 11 And so I feel like we made a lot of progress. 12 And all the things we're going to talk about here today 13 and maybe in the future are not about going back there 14 because I don't think there's any market participant -- 15 well, left -- who can with a straight face say that that 16 was good and we should go back there. The question is 17 can we bring, again, a balance back because we can 18 recognize the trend that I -- I wanted to show you, which 19 is that we've had a dearth of capital formation. 20 We've seen these slides before. And so if you 21 look at the slide carefully here, you can see not only 22 how we had fewer IPOs but what -- the size of IPOs -- the 23 number of small IPOs, which I'm defining as less than $60 24 million has gone down significantly. And that's really 25 what we're trying to talk about here. We're trying to 0154 1 talk about not just more IPOs. But for growth companies 2 where -- you can clearly see, we've seen a clear drop 3 off. 4 And why are we doing that? We're doing that 5 because at the end, if you look at the companies over 6 here, each one of these companies started as a small IPO. 7 Well, started before small IPO, but they came public as 8 small IPOs. 9 And I just had a conversation with the 10 gentleman who was a founder at Home Depot. And I hadn't 11 focused on Home Depot because it's not a technology 12 company; it's not a life science company. But Home Depot 13 -- $70 million public offering -- today Home Depot 14 probably doesn't get funded, period. If there's another 15 Home Depot out there -- and it has nothing to do with 16 technology or -- if there's another Home Depot out there 17 or a company like that, it probably doesn't get the 18 attention of investment banks or institutional investors. 19 And it's a numbers game. Let's think about 20 this for a second. In 1983 when Home Depot went public, 21 there were not trillion-dollar investment management 22 firms. Some of the biggest investment firms today that 23 we all have our money with, our 401(k)s with or wherever 24 -- or you've invested in mutual funds -- they're huge. 25 And so the dynamic is set up not to benefit the smaller 0155 1 companies. And the reason why -- part of the reason why 2 a number of companies are waiting to go public is because 3 they feel like they need to offer enough stock to the 4 marketplace to actually get large firms interested. 5 So, again, I think if our job here is to create 6 that balance for smaller companies, let's acknowledge the 7 fact that there has to be a different regime to induce 8 those big firms to actually carve out and grow their 9 small company portfolios because they think they can 10 provide positive returns for their investors. 11 And that's where this balance thing really 12 happens. If we do this right and if we get regulation 13 right and we can induce institutional investors who make 14 up the preponderance of the way that the retail investor 15 today enters the marketplace, if we can get them back, 16 they are the primary providers of equity capital for 17 America's growth. 18 So I actually -- I acknowledge that there's 19 room for conflict, and I acknowledge that there's always 20 going to be room for bad actors to do things they 21 shouldn't be doing. But I would say to you that there is 22 a far higher probability that market forces can conspire 23 to create positive good that benefits both individual 24 investors and institutional investors and companies. And 25 at the end of the day, that is the responsibility of all 0156 1 of us, regulators, market participants -- is to see if we 2 can find that center point and so that companies like 3 this can add to positive economic development. 4 So the three areas, I think, that are really 5 critical that we can talk about that have changed over 6 the last decade are just the change in market structure, 7 an increase in listing requirements, and changes in the 8 research ecosystem. And I'm not here to prescribe 9 outcomes today; I'm here just to highlight some of the 10 challenges. And we can talk about 11 -- if you want to talk about some of the potential 12 solutions, we can talk about them. But there are -- we 13 can acknowledge objectively that almost all of the 14 challenges that people agree that impacted capital 15 formation fall into one of these three buckets. 16 And so this is the problem as we've seen. And 17 I think we've all seen this statistic also, that IPOs -- 18 that we've seen a slowdown in the unemployment rate. And 19 there's a lot of debate around causality here, so I don't 20 want to spend a lot of time on this slide, but I think 21 the next one sort of sums it up. 22 The Kauffman Foundation talks about the fact 23 that from 1996 to 2010 IPOs created 2.3 million jobs, 24 which is a 45 percent increase in employment post-IPO. 25 And so they estimate that small company IPOs -- which 0157 1 their small company definition doesn't exactly line up 2 with ECG, but it's close enough for statistics, so -- 3 created about a million jobs or 156 percent growth. So 4 these firms have almost, you know, grown two and a half 5 times after they've gotten access to capital. 6 And so their estimate is -- which is, I think, 7 a lot more balanced than some of the other numbers we've 8 seen historically -- is between 1980 and 2000, had we 9 maintained that same growth trajectory as we had in the 10 20 years before the turn of the century, we would have 11 had another 1.9 million jobs from these companies. Now 12 that's just too much to ignore. And, again, if our job 13 is to help create economic -- a forum for capital 14 formation that leads to economic growth, we have a 15 responsibility to fix that. 16 We've gone through some of these numbers, so I 17 do think it's been -- you know, the JOBS Act was a great 18 start. And if I look at who’s benefitting -- total 19 dollars raised for all EGCs, by the way, all sectors, is 20 -- you know, let's talk about numbers -- $16.1 billion, so 21 big enough to be meaningful. But really at $16.1 billion 22 -- we live in a world where the largest 20 institutional 23 investors probably have close to a trillion dollars 24 apiece. Just --- it's not a lot. 25 And that's a theme that you'll hear me talk 0158 1 about because the changes and the improvement's we're 2 making -- some people will say that it's going to be 3 changing the entire way the business works. And the 4 reality is we're talking about just a small subsection 5 that we believe should be treated as a protected class. 6 And then we'll see how it goes. So it's actually -- I 7 don't think -- I think there's actually very little risk 8 in doing some of these things in terms of major market 9 impact but very high reward if we get it right. 10 And so I looked at the biotech industry. 11 Again, it's just an area we do a lot of work in. And I 12 just -- I want to be really clear. Everybody thinks 13 we're in the middle of the greatest biotech IPO market in 14 memory, and we are. But I want to put it in clear 15 numbers for you. $2 1/2 billion has been raised in the 16 biotech industry this year -- or actually since the JOBS 17 Act. That's 31 EGC companies. Just to put it in 18 perspective, I wanted you to know that the NIH budget for 19 this year is $147 billion. Again, I think we're doing 20 great things, but there's so much more to be done if you 21 really want to try to talk about making an impact. 22 In particular, in this area in drug discovery, 23 if I look at the drugs I know we funded that would not 24 have gotten funded, I mean it's just -- there's a whole 25 story line that goes to the good associated with getting 0159 1 orphan drugs funded that would never have seen the light 2 of day without access to public capital. 3 You know, one of the companies that we did 4 financing for is a company called Bluebird. Bluebird Bio 5 is working on a -- their lead compound is genetic -- it's 6 a gene therapy. And their lead compound is for 7 adrenoleukodystrophy, which is Lorenzo's Oil if you've 8 seen the movie, all right. I encourage you to go to the 9 website and learn about Ethan and learn about how, when 10 Ethan turned nine years old, he started seeing signs he 11 was not developing. And they misdiagnosed him with ADD. 12 And by the time he was 10, his brain had swelled, and it 13 was just a matter of time, all right. 14 That company got financed this year in part 15 because of Ethan's story but in part because we were 16 actually able to raise them a significant amount of 17 capital at a decent rate. And that trial, whether it's 18 successful or not -- we hope it will be -- is now funded. 19 And we'll see if we can get to an end point there. 20 These are very real stories, and I can tell you that 21 trial would not have been completed if we hadn't been 22 able to get the company public. 23 So who else benefits -- because not every 24 company out there is doing that kind of work -- you know, 25 individual and institutional investors -- so after market 0160 1 performance -- you know, if you look at the 64.4 percent 2 average price appreciation for EGC IPOs versus 26.2 3 percent for non-EGC IPOs -- pensions, pension funds. You 4 know, when you look at -- and they're clearly playing in 5 this space either through their institutional investment 6 arms or directly themselves. 7 And so I actually think in some respects we're 8 actually monetizing private portfolios that have been 9 private for a long time. And that recycling of that 10 capital for venture firms and for private equity firms 11 really goes to being able to provide positive returns for 12 investors more broadly, pensioners. 13 And so there's a whole host of people that 14 benefit. And to date we haven't seen the abuses that 15 people were concerned about. I'm always looking out for 16 them frankly, but we haven't seen them. 17 So I put it in the slide package, which you can 18 read at your leisure, the benefits. And I thought it 19 would be helpful to at least put some real stories in 20 from some real people on job growth. These are things 21 that -- where we've gotten some really positive feedback. 22 I went out to a few people when I knew I was going to do 23 this, and I said, "Can you give me your thoughts on job 24 growth or on the benefits of being a public company, on 25 the challenges of being a public company?" 0161 1 And so I think, if we can focus on the 2 challenges for a second, you know, for a small cap public 3 company the largest concern is building an investor 4 interest and maintaining liquidity in my stock. This is 5 a constant and continuous effort requiring significant 6 attention to the company's senior management team. So 7 here he's saying, "I could either spend my time focusing 8 on execution or helping to get liquidity on the stock. 9 Boy, it would be great if the liquidity in the stock 10 thing kind of took care of itself. I could spend a lot 11 more time executing." 12 Now I can tell you I know that contention 13 because I do have to get out on the road. We have one 14 research analyst that covers us. I would like to take an 15 insurance policy out on him because if he -- something 16 happens to him, I don't know who I'm going to go to 17 because I'm not sure there are other people that think 18 it's worthwhile to cover Cowen Group as a public company 19 because I just don't think we trade enough. Maybe we do, 20 but I'm not sure we do, and we're not likely to pay an 21 investment banking fee to someone for a while or at least 22 it's not obvious if we will. 23 So the interest on the part of the sell side 24 just to pick up Cowen group as a small company -- not 25 high, you know. And so I worry about it. He does a 0162 1 great job, and I'm always happy when he puts me in front 2 of institutional investors, but I have to do a lot of 3 asking for that. 4 So we still have challenges raising capital. I 5 think liquidity is one of them. Lack of research 6 sponsorship is another one -- regulatory burdens. You 7 know, there are certain aspects of the JOBS Act that have 8 not been implemented. We can talk about those, but if 9 you -- I tried to put it in a little chart here that 10 showed, you know, what are the challenges faced by a 11 small company. So each of these are addressed in some 12 fashion by the JOBS Act. Some have worked and some have 13 not. 14 I think if you look at scaled regulatory 15 requirements for small cap companies, it's something that 16 -- it's very real. We talk about it all the time. It's 17 certainly an inducement -- or it's certainly an 18 impediment -- I would say -- to people thinking about 19 becoming public. They are always looking at what they 20 have to do in terms of cost and expense and 21 infrastructure. 22 Reg A -- there's a wonderful section on Reg A 23 in the JOBS Act that just hasn't gone anywhere yet 24 because, again, as an issue -- as a capital raiser in the 25 market, until we get some clarification around state 0163 1 securities rules, it's just going to be hard to utilize 2 that. And I think that's a valuable path for a lot of 3 small companies to raise money. 4 In research we still haven't seen pre-IPO 5 research. The blackout periods for IPO research -- I 6 mean we've talked about it. There's just -- there are 7 some areas we can increase the opportunity for there to 8 be more research in the marketplace. And I think this is 9 one we can talk about a little bit. So I just -- if I 10 have a few more seconds, I'll just go through these 11 because I think it's really important to highlight them 12 in some level of detail. Then you can look at the 13 packet, and I'm always happy to answer questions. 14 This is interesting. So "Trading Liquidity - 15 Essential for Capital Formation" -- everyone thinks that 16 this is a individual versus institutional battle that 17 goes on here. Actually it isn't. You know, we've taken 18 a look at the data. The data suggests that, for 19 companies that are under $250 million, you know, 68 20 percent of those companies is owned by individuals. 21 There's a lot of capital formation that goes -- that 22 could go on there if we could induce the institutional 23 market -- the institutional investors to come back to 24 those markets. 25 Even if you were to go up to $500 million in 0164 1 market cap, you're only -- half of those companies are 2 still owned by individuals versus at a billion and north 3 -- you know, 83 percent are owned by institutions. And 4 this reflects our world and the post-Global Research Analyst 5 Settlement. And more liquidity means more people are 6 just focusing on bigger fund companies, bigger cap 7 companies. So I think there's a lot to be said for that. 8 And we talked about how, if we are going to 9 make changes to market structure to improve trading and 10 liquidity or recommend those, we're really talking about 11 a tiny subset, and that's the second chart here. Look at 12 it -- you know, you can see the chart -- the bars all the 13 way to the right are -- that's billion and north. So 14 you're talking about a tiny percentage of trading that we 15 think should be treated somewhat differently with a -- 16 maybe a modified market structure. 17 We talked about research and research 18 sponsorship. I gave you my own personal experience, but 19 you can look here, and you can see all of these 20 companies, 40 percent of the companies between $51 and $100 21 million market cap -- I only have one analyst. There's - 22 - if you're below $50 million, heaven help you trying to 23 get a research analyst. But even 24 -- you know, even between $100 and $200 it's still a -- 25 only a handful. 0165 1 When I talk to companies, they like to go -- if 2 they're going public, they want to have four to five. 3 It's really sort of -- everybody's trying to crowd four 4 or five research analysts onto the cover of an 5 underwriting. So if you're already public, it's really 6 hard unless you're doing the financing to add research 7 coverage. 8 And so I think we should be -- we can be doing 9 things to try and create a better economic model that 10 provides for maybe increased research in the marketplace. 11 And here I just want to say -- this is a huge hot button 12 issue that needs to be addressed and needs to be 13 addressed in a very balanced way, so I go back to my 14 theme of balance. 15 Right now for these companies, the way the 16 market is set up we're telling these companies it's 17 better to have no information than potentially biased 18 information about you. So I want to be really clear 19 about that. If investors are making investment decisions 20 based only on sell side research, that's a mistake. 21 Institutional investors do not read a research report and 22 buy stocks. Individual investors should never do that, 23 and that needs to be really clear. 24 But more information in the marketplace about 25 the prospects of a company is a good thing even if people 0166 1 read it and say, "I think this could be biased." So -- 2 because what is happening in some instances -- in a 3 number of instances we have a number of venues now where 4 people can take opposing views and publish them. You 5 know, we all see them. Seeking Alpha is a wonderful 6 repository of great information. Here's the difference 7 though. In the absence of research, that becomes the 8 standard. And there's no certification for those pieces. 9 So we have this great Reg AC (Regulation Analyst Certification) regime here and 10 this great research independence mandate that should be 11 upheld in every way possible, and we make it really hard 12 for those analysts who write research for emerging growth 13 companies because of the compliance requirements. So 14 we'd rather have -- the way it stands today we'd rather 15 have non-certified people in open forums providing the 16 only source of information for many of these micro cap 17 companies. 18 I would argue that we're better off being in an 19 environment where we have more information even if that 20 information is potentially biased and is labeled as such 21 with conflicts -- which it already is -- than having no 22 information. And so we should be asking ourselves the 23 questions, "What do we need to do in order to induce sell 24 side firms to produce more research for debate and 25 educating individual investors about the dangers of 0167 1 reading a research report and buying a stock," because 2 the real investors do not do that. 3 And so if we can create that kind of framework 4 where we could get more information labeled as such, we 5 will end up in a situation where more idea flow comes and 6 more institutional investors are likely to come back to 7 the market. 8 I'll give you an example in our own stock, all 9 right. We had a decent second quarter for the first time 10 in a while. And our stock was trading around $3.30 a 11 share when we announced. We did our morning call. There 12 were a few crickets chirping on the other end of the 13 phone. Most of the people who dialed in were our 14 employees. A few of our biggest investors were there, 15 but by and large nobody listened. Maybe people read the 16 transcript, but whatever. There weren't a lot of people 17 on the call, no different than any other quarter. 18 We did this announcement. We're feeling pretty 19 good about it because we had a decent quarter. Stock 20 trades down 10 cents on like 250,000 shares. We're like, 21 "Wow. Okay. Let's go back to work," because we know if 22 we keep doing it, eventually that's going to get 23 rectified. 24 Over the weekend the one research analyst we 25 have writes a research report on us unbeknownst to us. 0168 1 He didn't call us to say, "I'm going to write a research 2 report." He just -- he took what we said, he synthesized 3 it, he added to it, and he extended the investment theme 4 in ways we can't do because of Reg FD. And he got most 5 of it right frankly. It was a good piece. 6 We were up 40 cents. Then we traded 2 1/2 7 million shares on Monday. Now when I hear people tell me 8 that sell side research doesn't matter, I know first-hand 9 that it does. Nothing changed between Friday's earnings 10 call and Monday's research report other than an 11 independent person took what we said and added and 12 extended that thesis and called a few institutional 13 accounts and said, "Hey, you should take a look at what's 14 going on at Cowen Group. Here's my research report." 15 That's a big difference. Now we still have to 16 produce in order for that to be sustained. I'm not 17 resting on those laurels. I feel like a lot of pressure. 18 Now I've got to produce a lot to make sure we hit those 19 numbers. But the fact of the matter remains -- is we 20 didn't do anything different on Monday than we did on 21 Friday. And so I can tell you first-hand that sell side 22 research in this day and age, post-Global Research Analyst Settlement, 23 with Reg AC and all the independent requirements is good, 24 better than not having any. 25 And if you're a bad analyst, I promise you, you 0169 1 get weeded out quickly. So if you're an analyst who just 2 writes stuff that doesn't perform for people, people just 3 stop listening and -- as it should be by the way, as it 4 should be. 5 And so I feel like we had to clean up a lot of 6 the act, as I told you, at the end of the last century. 7 A lot of bad stuff was going on. That needed to happen. 8 But we should probably take a fresh look at whether or 9 not some of those things can be scaled back moderately 10 for a small subset of companies that could benefit from 11 having more information in the marketplace rather than no 12 information in the marketplace. 13 And so with that I'll stop. I think we've 14 covered a number of grounds, but I just think now seems 15 to be as good a time as any to have this discussion. And 16 I appreciate the fact that this group provides a forum 17 where we can come in and have this kind of discussion and 18 debate and hopefully have it be heard and resonate. So 19 thank you. 20 MR. GRAHAM: Well, thank you, Jeff, and thank 21 you, Joel and Alex. 22 We have a few more minutes, and I guess, you 23 know, one thing that I just wanted to put to you three -- 24 you know, clearly there have been a lot of benefits from 25 the JOBS Act. And clearly it's -- and the JOBS Act has 0170 1 changed the way IPOs are done. And as you pointed out, a 2 lot of that is good. What I'm a little bit afraid of is, 3 while it will change the way IPOs are done, we haven't 4 necessarily come up with a way to generate more IPOs. 5 If you -- and one of the things that we've been 6 focused on from the beginning is how do you bring back 7 the smaller IPO. And if you look -- I think I've got 8 this right. If you look at the stats, IPOs that raise 9 $100 million or less -- there are actually fewer of those 10 done after the JOBS Act than before. And so I see a gap 11 there, and you know, clearly there are some needs. And I 12 think, Jeff, you were kind of alluding to this. You 13 know, there needs to be a way to address that market if 14 you will. 15 MR. SOLOMON: Yeah. 16 MR. GRAHAM: And, you know, one of the things 17 that we as a committee are searching for or -- you know, 18 what can be done in terms of changing market structure, 19 somehow generating research, you know, all the things 20 that people have kind of talked about. And maybe there 21 is a JOBS Act II coming. But any thoughts that you might 22 have in that regard would be -- I'm sure you've thought 23 about it. 24 MR. SOLOMON: Yeah. I mean I -- you want to, 25 guys? 0171 1 MR. TROTTER: Go ahead. 2 MR. SOLOMON: So I think in some respects, you 3 know, Rome wasn't built in a day, all right. And so I 4 don't want to understate what the JOBS Act has done in 5 terms of providing a framework. But like everything, you 6 know, we've got to get people to change their mindset and 7 their business models a little bit. So we've had 10 or 8 15 years, almost 15 years in which going public wasn't at 9 the forefront of peoples' minds. In fact, they were 10 building businesses that didn't require a lot of capital 11 because they were worried they wouldn't be able to fund 12 them. 13 So interestingly enough, like when you see 14 social networking companies and software companies going 15 public, those are not big capital users. You know, we're 16 in a market now that a data networking company -- it's 17 the first data networking IPO in like five years. Think 18 about all the data networking companies that went public 19 that are -- actually, you know, we could argue about 20 whether they were right or wrong pricing-wise. But 21 Cisco? I mean Juniper? These are huge users and 22 consumers of capital and creators of jobs. 23 And the business model in the venture community 24 over the last decade has not -- has been to focus on 25 companies that do not require the public markets in order 0172 1 to create exits. So that's going to take some time. A 2 lot of them have been funded companies they think can be 3 sold to bigger companies because that's a better -- you 4 know, you got to have exits if you're going to be raising 5 more money. Venture guys are capitalists. They've got 6 to have -- they've got to see where the door is going to 7 be. 8 So better to fund a company -- med devices is a 9 great example. If you're going to build a med device 10 company, you better make sure it fits into Stryker's 11 portfolio or J&J's portfolio. There's like four or five 12 consolidators. 13 I would argue we got some great companies in 14 the -- you know, 10 years ago that got funded that 15 actually -- you know, Guidant was a great company for a 16 long time until they had issues from a -- you know, they 17 were an innovator that had great impact and great job 18 creation. You know, if Guidant had been a stent company 19 that was geared to selling to J&J out of the gate, it 20 never would have ever done what it did. 21 And so it's going to take some time for people 22 to get their heads around the fact that going public is 23 actually -- funding companies that need to raise equity 24 capital is an okay business strategy. That's first. 25 The second is we really do need to address 0173 1 market structure in a meaningful way. And it -- you 2 know, there's been a lot of great changes that have 3 occurred to market structure that should not go -- that 4 we should not change back. So -- and everyone talks 5 about tick increment and quote size. For the vast 6 majority, as we've demonstrated, nothing should change. 7 But for this group we should be discussing 8 whether or not there needs to be a change that fosters 9 liquidity. So not changing economics so much but can we 10 put a simpler framework in place where institutional 11 investors feel like they can actually engage in price 12 discovery without getting front-run. We don't have that 13 today. And so they're -- because they're big and because 14 they need to move a lot of capital around, it's just 15 easier for them to say, "I'm not going to focus on that." 16 And so we've got to demonstrate it's okay to 17 come back to the marketplace where we've -- and that's 18 where, you know, I think sell side firms have been hugely 19 beneficial as middlemen to create that liquidity that 20 attracts fundamental buyers and sellers. 21 And so there are some things we can do there. 22 And I think if we're able to do those things, we'll look 23 back in 10 years, which is kind of -- you've got to take 24 a long-term view here. And we'll say, "Wow. Look at all 25 the companies that became public." But if we expect the 0174 1 giant -- the little acorns to be giant oaks in the first 2 year and that's going to be our judgment period, that 3 doesn't happen. 4 And so we can do a lot of things here and tell 5 -- and particularly the SEC can do a lot of things here 6 to seemingly help and have such a short judgment period 7 that we'll never get from here to there. And so you've 8 got to give it some time and let's see if it regenerates. 9 And if it does, I think you're going to find that people 10 are going to be a lot more productive. 11 MR. TROTTER: I would just add to that -- and 12 Jeff, you put your finger on something really significant 13 when you talk about basically how IPOs have to compete 14 with the M&A company sale as a means of capital formation 15 for companies providing an exit to their early stage 16 investors. And that was really at the heart of a lot of 17 where we started on the IPO Task Force, which is you look 18 at the last two decades of IPO activity, and you see the 19 dramatic fall-off in the most recent decade. 20 You also -- over the same period you see 21 another trend, which is where two decades ago the trend 22 was roughly 50/50 M&A versus IPO as the method of exiting 23 and providing returns to the early stage investors. Now 24 it has been part of the JOBS Act. It's been 90 percent 25 private company sale as the exit and only 10 percent of 0175 1 these companies are getting out as public companies. 2 And first year of experience has not been bad. 3 It's been pretty darn good. I think, Jeff, you're 4 right. Over time what we would hope to see is, maybe 5 through some additional reforms but also just with 6 additional track record, as more small companies are 7 drawn to the process, as they're no longer deterred by 8 some of the -- you know, the confidential process, for 9 example, removes a significant deterrent for a lot of 10 these companies weighing those two alternatives of 11 selling the company privately versus going public. 12 These, over the long term, could be really -- 13 could have a significant impact, Steve, toward the point 14 that you're making where are we really going to see the 15 kind of bump that we want to see in the really smaller 16 company IPOs not just more IPOs of really large 17 companies. 18 MR. GRAHAM: Okay. Well, thank you for that, 19 and thank you again to our panel. We're going to take a 20 short break and then reconvene at 3:30 sharp. 21 (A brief recess was taken.) 22 MR. GRAHAM: Okay. Well, I think we had a good 23 meeting today. Our speakers, I think, were well 24 prepared, and I, for one, learned a fair amount. One of 25 the things that was really brought home to me -- and that 0176 1 is that we seem to have some real issues with the 2 proposed rule under Regulation D. And as I said earlier 3 today, I'm not sure what the answers are. I think it 4 does require more thought. 5 It's clear that the SEC has done a lot of work 6 on this, but I think it's equally clear that it might be 7 a good idea to think about these things a little bit more 8 before things are set. 9 My concern -- and I hope you share that -- is 10 that of the -- the rules as drafted might have the 11 opposite effect of what we're trying to do here, and that 12 is to facilitate capital raising obviously and also work 13 to protect investors. But certainly we don't want to 14 make capital raising more difficult, and if we're dealing 15 with a system that needs to work, I think we need to find 16 ways to make it work better as opposed to finding ways to 17 create friction. 18 And so I don't think we have enough time to 19 think through many of the things that need to be thought 20 through, but what I would like to put on the table is a 21 recommendation that we ask the Commission to extend the 22 comment period so that more of these thoughts can be 23 articulated, more of these issues, and give ourselves a 24 little bit more time to vet some of the issues. So I'd 25 like to hear from you. 0177 1 MR. YADLEY: So moved. 2 A PARTICIPANT: Second. 3 A PARTICIPANT: Second. 4 MR. GRAHAM: Okay, moved and seconded. Let's - 5 - have any other comments? 6 MR. YADLEY: I think what you just said is 7 spot-on. The -- our very first recommendation was to 8 focus on who bought securities privately, not how they 9 were found. Fortunately that made its way in the JOBS 10 Act. But very specifically and in pretty much in that 11 same vein it said -- well, we know what it said, that -- 12 eliminate the prohibition on general solicitation for 506 13 offerings made solely to accredited investors. Congress 14 added the verification but didn't say, "Change the rest 15 of the rule." 16 And so I think that we should be cautious in 17 making changes, especially to a reporting forum, the 18 initial purpose of which was to provide analytical and 19 statistical data, that that doesn't swallow up the 20 benefits of the expanded exemption that Congress and this 21 committee endorsed. 22 MR. GRAHAM: Thank you, Greg. 23 Any other comments? 24 (No response.) 25 MR. GRAHAM: Okay. All those in favor? 0178 1 (Chorus of ayes.) 2 MR. GRAHAM: Okay. All those opposed? 3 MR. BOCHNOWSKI: Aye. 4 MR. GRAHAM: Oh. That was David. Thank you, 5 David. It sounded like an aye. 6 MR. BOCHNOWSKI: I've been on the call since 7 earlier, but somehow I just got cleared to -- 8 MR. GRAHAM: Yeah. We wanted to hear your aye. 9 Now -- okay. Well, again, as Chris and I had an 10 opportunity to speak with most of you over the last few 11 months -- and at that time we didn't know whether or not 12 this committee was going to be re-chartered. As we heard 13 this morning, it will be re-chartered, and so we have to 14 take the next few days and weeks to figure out exactly 15 what that means. 16 But for the time being I would like to say that 17 it's been a fast two years, and I've enjoyed working with 18 all of you. And once again, I'd like to thank each of 19 you for your contributions and your efforts. 20 Chris, do you have anything to add? 21 MS. JACOBS: Only that I totally concur with 22 the thanks, the commitment, the attendance, and your 23 candor. What has really become clear, especially as we 24 have made our recommendations over the past few years, is 25 that they have been thoughtful on our part, brought to us 0179 1 by people who are out there doing it every day. And for 2 that we thank you because it's very clear our work has 3 become important and that folks are paying attention to 4 what we see and experience every day. Case in point was 5 Catherine's issue today. So thank you all again for a 6 great two years. 7 MR. GRAHAM: Okay. Can I get a motion to -- 8 MR. LEZA: Thank you for your leadership. 9 MR. GRAHAM: Thank you, Richard. 10 Can I get a motion to adjourn? 11 MR. CHACE: So moved. 12 A PARTICIPANT: Second. 13 MR. GRAHAM: All right. All those in favor? 14 (Chorus of ayes.) 15 MR. GRAHAM: What about you, David? 16 MR. BOCHNOWSKI: I'm an aye. 17 MR. GRAHAM: Okay. I guess we're done. Thank 18 you all. 19 (Whereupon, at 3:19 p.m., the proceedings were 20 concluded.) 21 22 23 24 25 0180 1 PROOFREADER'S CERTIFICATE 2 3 In The Matter of: SMALL AND EMERGING COMPANIES ADVISORY 4 COMMITTEE MEETING 5 File Number: OS-917 6 Date: September 17, 2013 7 Location: Washington, D.C. 8 9 This is to certify that I, ______________, 10 (the undersigned), do hereby swear and affirm that the 11 attached proceedings before the U.S. Securities and 12 Exchange Commission were held according to the record and 13 that this is the original, complete, true and accurate 14 transcript that has been compared to the reporting or 15 recording accomplished at the hearing. 16 17 _______________________ _______________________ 18 (Proofreader's Name) (Date) 19 20 21 22 23 24 25 0181 1 REPORTER'S CERTIFICATE 2 3 I, Beth Roots, reporter, hereby certify that the 4 foregoing transcript of 179 pages is a complete, true and 5 accurate transcript of the testimony indicated, held on 6 September 17, 2013 at Washington, D.C. in the matter of: 7 SMALL AND EMERGING COMPANIES ADVISORY COMMITTEE MEETING. 8 9 I further certify that this proceeding was recorded by 10 me, and that the foregoing transcript has been prepared 11 under my direction. 12 13 14 Date:__________________________ 15 Official Reporter:__________________________ 16 Diversified Reporting Services, Inc. 17 18 19 20 21 22 23 24 25